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A B S T R A C T
Background
Helicobacter pylori (H pylori) infection has been implicated in a number of malignancies and non-malignant conditions including
peptic ulcers, non-ulcer dyspepsia, recurrent peptic ulcer bleeding, unexplained iron deficiency anaemia, idiopathic thrombocytopaenia
purpura, and colorectal adenomas. The confirmatory diagnosis of H pylori is by endoscopic biopsy, followed by histopathological
examination using haemotoxylin and eosin (H & E) stain or special stains such as Giemsa stain and Warthin-Starry stain. Special stains
are more accurate than H & E stain. There is significant uncertainty about the diagnostic accuracy of non-invasive tests for diagnosis
of H pylori.
Objectives
To compare the diagnostic accuracy of urea breath test, serology, and stool antigen test, used alone or in combination, for diagnosis of
H pylori infection in symptomatic and asymptomatic people, so that eradication therapy for H pylori can be started.
Search methods
We searched MEDLINE, Embase, the Science Citation Index and the National Institute for Health Research Health Technology
Assessment Database on 4March 2016. We screened references in the included studies to identify additional studies. We also conducted
citation searches of relevant studies, most recently on 4 December 2016. We did not restrict studies by language or publication status,
or whether data were collected prospectively or retrospectively.
Selection criteria
We included diagnostic accuracy studies that evaluated at least one of the index tests (urea breath test using isotopes such as 13C or
14C, serology and stool antigen test) against the reference standard (histopathological examination using H & E stain, special stains or
immunohistochemical stain) in people suspected of having H pylori infection.
Data collection and analysis
Two review authors independently screened the references to identify relevant studies and independently extracted data. We assessed the
methodological quality of studies using the QUADAS-2 tool. We performed meta-analysis by using the hierarchical summary receiver
operating characteristic (HSROC) model to estimate and compare SROC curves. Where appropriate, we used bivariate or univariate
logistic regression models to estimate summary sensitivities and specificities.
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Main results
We included 101 studies involving 11,003 participants, of which 5839 participants (53.1%) had H pylori infection. The prevalence
of H pylori infection in the studies ranged from 15.2% to 94.7%, with a median prevalence of 53.7% (interquartile range 42.0% to
66.5%). Most of the studies (57%) included participants with dyspepsia and 53 studies excluded participants who recently had proton
pump inhibitors or antibiotics.There was at least an unclear risk of bias or unclear applicability concern for each study.
Of the 101 studies, 15 compared the accuracy of two index tests and two studies compared the accuracy of three index tests. Thirty-four
studies (4242 participants) evaluated serology; 29 studies (2988 participants) evaluated stool antigen test; 34 studies (3139 participants)
evaluated urea breath test-13C; 21 studies (1810 participants) evaluated urea breath test-14C; and two studies (127 participants)
evaluated urea breath test but did not report the isotope used. The thresholds used to define test positivity and the staining techniques
used for histopathological examination (reference standard) varied between studies. Due to sparse data for each threshold reported, it
was not possible to identify the best threshold for each test.
Using data from 99 studies in an indirect test comparison, there was statistical evidence of a difference in diagnostic accuracy between
urea breath test-13C, urea breath test-14C, serology and stool antigen test (P = 0.024). The diagnostic odds ratios for urea breath test-
13C, urea breath test-14C, serology, and stool antigen test were 153 (95% confidence interval (CI) 73.7 to 316), 105 (95% CI 74.0 to
150), 47.4 (95% CI 25.5 to 88.1) and 45.1 (95% CI 24.2 to 84.1). The sensitivity (95% CI) estimated at a fixed specificity of 0.90
(median from studies across the four tests), was 0.94 (95% CI 0.89 to 0.97) for urea breath test-13C, 0.92 (95% CI 0.89 to 0.94) for
urea breath test-14C, 0.84 (95% CI 0.74 to 0.91) for serology, and 0.83 (95% CI 0.73 to 0.90) for stool antigen test. This implies that
on average, given a specificity of 0.90 and prevalence of 53.7% (median specificity and prevalence in the studies), out of 1000 people
tested forH pylori infection, there will be 46 false positives (people without H pylori infection who will be diagnosed as having H pylori
infection). In this hypothetical cohort, urea breath test-13C, urea breath test-14C, serology, and stool antigen test will give 30 (95% CI
15 to 58), 42 (95% CI 30 to 58), 86 (95% CI 50 to 140), and 89 (95% CI 52 to 146) false negatives respectively (people with H pylori
infection for whom the diagnosis of H pylori will be missed).
Direct comparisons were based on few head-to-head studies. The ratios of diagnostic odds ratios (DORs) were 0.68 (95% CI 0.12 to
3.70; P = 0.56) for urea breath test-13C versus serology (seven studies), and 0.88 (95% CI 0.14 to 5.56; P = 0.84) for urea breath test-
13C versus stool antigen test (seven studies). The 95% CIs of these estimates overlap with those of the ratios of DORs from the indirect
comparison. Data were limited or unavailable for meta-analysis of other direct comparisons.
Authors’ conclusions
In people without a history of gastrectomy and those who have not recently had antibiotics or proton ,pump inhibitors, urea breath tests
had high diagnostic accuracy while serology and stool antigen tests were less accurate for diagnosis of Helicobacter pylori infection.This
is based on an indirect test comparison (with potential for bias due to confounding), as evidence from direct comparisons was limited
or unavailable. The thresholds used for these tests were highly variable and we were unable to identify specific thresholds that might be
useful in clinical practice.
We need further comparative studies of high methodological quality to obtain more reliable evidence of relative accuracy between the
tests. Such studies should be conducted prospectively in a representative spectrum of participants and clearly reported to ensure low
risk of bias. Most importantly, studies should prespecify and clearly report thresholds used, and should avoid inappropriate exclusions.
P L A I N L A N G U A G E S U M M A R Y
Accuracy of different non-invasive methods for identifying Helicobacter pylori
Why is it important to know whether someone has Helicobacter pylori?
Helicobacter pylori (H pylori) is a type of bacteria which may be present in the stomach of some people. H pylori is believed to cause a
number of cancers, including stomach cancer, pancreatic cancer, and throat cancer.H pylori is also linked with other diseases including
stomach ulcers, heart burn, and a bloated feeling. If H pylori is found in an individual, appropriate treatment can be started.
What is the aim of this review?
To compare the accuracy of three different types of test for H pylori. These are: urea breath tests, blood tests (the specific blood test is
called serology), and stool tests (in faeces).
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What was studied in this review?
There are two types of urea breath test which use two different forms of carbon known as 13C and 14C, as well as multiple versions of
serology and stool tests.
What are the main results of the review?
We found 101 studies which included 11,003 people who were tested for H pylori. Of these 11,003 participants, 5839 (53.1%) had
H pylori infection. All the studies used one of the three tests listed above and compared these test results with the diagnosis given by
endoscopic biopsy. Endoscopic biopsy involves obtaining tissue from the stomach using a thin flexible tube introduced through the
mouth and testing for the presence of H pylori under the microscope. It is currently the most accurate available test, however it causes
physical discomfort to the patient, with associated risks for harm. This is in contrast to the alternative non-invasive tests in this review
which are significantly less uncomfortable and have minimal or no risk of harm, making them desirable alternatives if they can be
shown to be as accurate at diagnosing H pylori as endoscopic biopsy. Most of the studies included participants with heart burn or similar
problems in the stomach and excluded participants who had previously undergone partial removal of the stomach and those having
treatment for H pylori.
Thirty-four studies (4242 participants) used serology; 29 studies (2988 participants) used stool antigen test; 34 studies (3139 partici-
pants) used urea breath test-13C; 21 studies (1810 participants) used urea breath test-14C; and two studies (127 participants) used urea
breath test but did not report the type of carbon used. Studies varied in the limit they used before saying a test was positive forH pylori
infection and the type of stains used to examine the biopsy material. When we looked at all the data we found that urea breath tests
were more accurate than blood and stool tests. The results mean that, on average, if 1000 people are tested, there will be 46 people
without H pylori who will be misdiagnosed as having H pylori. Also, there will be 30, 42, 86, and 89 people with H pylori infection for
whom the diagnosis of H pylori infection will be missed by urea breath test-13C, urea breath test-14C, serology, and stool antigen test,
respectively. When we looked at the seven studies which compared urea breath test-13C and serology, or urea breath test-13C and stool
antigen tests in the same participants, the results were uncertain and we cannot tell which test is more accurate.
How reliable are the results of the studies?
Except for one study, all the studies were of poor methodological quality, which makes their results unreliable.
Who do the results of this review apply to?
These results apply to children and adults with suspected H pylori infection, but only in those who have not previously undergone
stomach operations and those who have not recently had antibiotics or treatment for H pylori infection.
What are the implications of this review?
Urea breath tests, blood tests, and stool tests may be suitable for identifying whether someone hasH pylori infection. However, the level
of the result of urea breath test, blood test, or stool test which should be used to make a diagnosis of H pylori infection remains unclear.
How up-to-date is the review?
We performed a thorough literature search for studies reporting the accuracy of these different tests until 4 March 2016.
B A C K G R O U N D
Helicobacter pylori (H pylori) is a gram negative spiral bacterium
(NCBI 2014). Approximately 13% to 81% of people have H py-
lori infection (Peleteiro 2014). Prevalence of the bacterium varies
according to age (generally increasing with age, although infection
rates tend to fall among older age groups in some Latin Ameri-
can and Northeast Asian countries); region (lower infection rates
are seen in Australia and the UK, while higher rates are reported
in Chile, China, Japan, Korea, and Latvia); race (more prevalent
amongst Afrocarribeans compared to white people); and socioe-
conomic class (more common in poorer settings) (Graham 1991;
Laszewicz 2014; Muhsen 2012; Peleteiro 2014).
3Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Based on observational studies, H pylori infection has been im-
plicated in a number of malignancies, including gastric cancer,
premalignant lesions of the stomach (atrophic gastritis and in-
testinal metaplasia), gastric lymphoma, pancreatic cancer, colorec-
tal cancer, and laryngeal cancer (Huang 1998; Huang 2003; Wu
2013; Xiao 2013; Xue 2001; Zhuo 2008). However, H pylori is
associated with a lower incidence of oesophageal adenocarcinomas
(Islami 2008). H pylori is also associated with a number of non-
malignant conditions, including peptic ulcers, non-ulcer dyspep-
sia, recurrent peptic ulcer bleeding, unexplained iron deficiency
anaemia, idiopathic thrombocytopaenia purpura, and colorectal
adenomas (DuBois 2005; Franchini 2007; Gisbert 2004b; Huang
2002; Jaakkimainen 1999; Wu 2013).
Although a number of pathogenic factors such as cytotoxin-asso-
ciated gene A (CagA), vacuolating cytotoxin A (VacA), and blood
group antigen binding adhesin (BabA) are associated with in-
creased virulence of H pylori (Huang 2003; Malfertheiner 2012),
detection of these pathogenic factors currently has no role in the
management of H pylori infection (Malfertheiner 2012). The rec-
ommended initial treatment for H pylori infection is with a com-
bination of a proton pump inhibitor, clarithromycin, and amox-
icillin or metronidazole (triple therapy) in regions with low resis-
tance to clarithromycin (< 20% resistance rate in the area), and
the triple therapy along with bismuth (quadruple therapy) in re-
gions with high resistance to clarithromycin (> 20% resistance
rate in the area) (Malfertheiner 2012). If this results in failure
of eradication, bismuth-quadruple therapy or levofloxacin-triple
therapy (replacement of clarithromycin with levofloxacin in the
classical triple therapy) when triple therapy was used as the initial
treatment and levofloxacin-triple therapy when bismuth quadru-
ple therapy was used as the initial treatment is recommended
(Malfertheiner 2012). If even this treatment fails to eradicate H
pylori, then further treatment should be based on antibiotic sus-
ceptibility (Malfertheiner 2012). Eradication of H pylori might
lead to a decrease in malignant and non-malignant conditions as-
sociated withH pylori infection. Adverse events related toH pylori
treatment include taste disturbance, diarrhoea, nausea, headache,
skin rash, abdominal pain, dizziness, bloating, myalgias (muscle
pain), and constipation (Ye 2014).
A glossary of terms is included in Appendix 1.
Target condition being diagnosed
Helicobacter pylori infection.
Index test(s)
Urea breath test
The urea breath test is based on the presence of urease enzyme in
live H pylori which breaks down urea into ammonia and carbon
dioxide (McNulty 2005; Ricci 2007). After ingestion of urea la-
belled with either 13C or 14C, breath samples are collected for up
to 30 minutes by exhaling into a carbon dioxide-trapping agent
(Ricci 2007). The urea breath test is performed by the clinician
or the clinician’s assistant. The thresholds used include the per-
centage of carbon recovered during the collection time or counts
per minute (Ferwana 2015). Threshold levels above 4% or 5% are
commonly used to diagnose H pylori infection (Ferwana 2015).
A wide range of threshold counts per minute, ranging from more
than 25 counts per minute to 1000 counts per minute, have been
used for diagnosis of H pylori infection (Ferwana 2015).
Serology
These tests are based on circulating antibodies to H pylori. There
are three main methods for these tests: the enzyme-linked im-
munosorbent assay (ELISA) test, latex agglutination tests, and
Western blotting (Ricci 2007). Of these, ELISA is the most com-
monly used method. Total immunoglobulin, immunoglobulin
subtypes, and antibody response to specific antigens can all be
tested. Since they do not require any special equipment, they can
be easily performed (Ricci 2007). However, serology may be pos-
itive because of the presence of active infection at the time of the
test, previous infection, or because of non-specific cross-reacting
antibodies (McNulty 2005). Tests that use whole blood (rather
than serum) and other bedside tests (using a bedside centrifuge)
are also available, although these whole-blood tests and bedside
serum tests are generally considered unreliable (Ricci 2007). Rou-
tine serum tests are performed by the laboratory technician and
interpreted by the clinician. The bedside serum tests and whole-
blood tests are performed by the clinician or the clinician’s assis-
tant. Different researchers evaluating the prevalence of H pylori
have used different thresholds to define the positivity of serology,
for example Lindsetmo 2008 used a titre ≥ 300 while Granberg
1993 used a titre ≥ 500.
Stool antigen tests
These tests use monoclonal and polyclonal antibodies to detect the
presence of H pylori antigen in stools and activeH pylori infection
can be diagnosed (McNulty 2005; Ricci 2007). Serum tests are
performed by the laboratory technician and interpreted by the
clinician. Several thresholds have been used for other tests, for
example, an optical density of≥ 0.15,≥ 0.16, and≥ 0.19 have all
been used as thresholds for diagnosis ofH pylori using monoclonal
antibodies for stool antigen tests.
Clinical pathway
4Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Evidence from randomised controlled trials (RCTs) showed that
screening and eradication programmes forH pylori in populations
at high risk of gastric cancer (e.g. East Asians) lowered the inci-
dence of gastric cancer (Ford 2014). The Asia-Pacific Gastric Can-
cer Consensus conference recommended that screening and eradi-
cation ofH pyloriwas advisable in populations in countries at high
risk of gastric cancer (i.e. Japan and Korea) (Talley 2008). The up-
dated EuropeanHelicobacter StudyGroup (EHSG) FourthMaas-
tricht/FlorenceConsensusConference guidelines suggest that peo-
ple should be tested for H pylori, and eradication of H pylori
(when present) has been recommended for the following condi-
tions (Malfertheiner 2012):
1. People at high risk of gastric cancer.
2. Adults with dyspepsia with a locally-determined age cut-off
point (depending on local incidence of gastric cancer in different
age groups), and without ‘alarm’ symptoms or signs associated
with an increased risk of gastric cancer such as weight loss,
dysphagia, upper gastrointestinal bleeding, abdominal mass, or
iron deficient anaemia.
3. Unexplained iron deficiency anaemia.
4. Idiopathic thrombocytopenic purpura.
5. Uninvestigated young patients with dyspepsia should also
be considered for testing for H pylori when the prevalence of H
pylori is high (≥ 20%).
The clinical pathway is shown in Figure 1.
Figure 1. Clinical pathway
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Prior test(s)
The index tests can be performed without any prior test.
Role of index test(s)
The index tests are used for screening and diagnosis of H pylori.
Alternative test(s)
Other tests used in the screening and diagnosis of H pylori in-
fection include non-invasive saliva and urine antigen-based tests
(Ricci 2007), and invasive gastric biopsy followed byCampylobac-
ter-like organism (CLO) test, culture, histology, and polymerase
chain reaction (PCR) (Van Doorn 2000). We do not include non-
invasive saliva and urine antigen-based tests in this review because
these tests are not commonly used (Ricci 2007).
Rationale
Testing for H pylori and eradication of H pylori have been recom-
mended for a number of population groups (Clinical pathway).
These tests have to be non-invasive so that a large number of peo-
ple can be tested. People with undetected H pylori continue to
be at high risk of gastric cancer or continue to have dyspepsia,
anaemia, or purpura. Overdiagnosis (false positive test results) of
H pylori means that patients are subject to unnecessary adverse
events related to eradication therapy (approximately 27% of pa-
tients receiving eradication therapy develop mild adverse events
such as bitter taste, nausea, diarrhoea, etc.). Comparing the diag-
nostic accuracy of different index tests will highlight the best test
for the diagnosis of H pylori infection.
O B J E C T I V E S
To compare the diagnostic accuracy of urea breath test, serology,
and stool antigen test, alone or in combination, for diagnosis of
H pylori infection in symptomatic and asymptomatic people, so
that eradication therapy for H pylori can be started.
Secondary objectives
To investigate the following potential sources of heterogeneity:
type of reference standard, risk of bias, publication status, prospec-
tive versus retrospective studies, symptomatic versus asymptomatic
participants, recent or current use of proton pump inhibitors or
antibiotics, different subtypes of tests, and the interval between
the index test and reference standard.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We include studies that evaluate the accuracy of the index tests
in the appropriate patient population (see Participants), regardless
of language or publication status, or whether data were collected
prospectively or retrospectively. However, we exclude reports that
describe how the diagnosis of H pylori was made in an individual
patient or group of patients, and which do not provide sufficient
diagnostic test accuracy data (i.e. the number of true positives, false
positives, false negatives, and true negatives). We also exclude case-
control studies because these are prone to bias (Whiting 2011).
Participants
Symptomatic and asymptomatic people in whom H pylori infec-
tion status is sought so that eradication therapy forH pylori can be
started. We exclude studies that included only people with acute
upper gastrointestinal bleeding because such patients are likely to
undergo endoscopy and invasive testing can be performed, if re-
quired.
Index tests
Urea breath test-14C, urea breath test-13C, serology, and stool anti-
gen test, alone or in combination. We included only initial test-
ing and excluded repeat testing (monitoring success of treatment),
since diagnostic accuracy may vary depending on the purpose of
testing (Ricci 2007).
Target conditions
H pylori infection.
Reference standards
There is no gold standard for diagnosis of H pylori infection and
the diagnosis is made by a combination of tests following en-
doscopic biopsy; endoscopic biopsy followed by histology, en-
doscopic biopsy followed by polymerase chain reaction (PCR),
and endoscopic biopsy followed by rapid urease testing all have
excellent sensitivity and specificity (Chey 2007). However, PCR
methodology is not standardised across laboratories (Chey 2007);
it is an unreliable reference standard. Endoscopic biopsy followed
by rapid urease testing has poor sensitivity following treatment
with proton pump inhibitors (Chey 2007). Endoscopic biopsy
with culture has high specificity but poor sensitivity (Chey 2007).
We therefore considered only endoscopic biopsy followed by his-
tology (using haemotoxylin and eosin (H & E) stain, special his-
tological stains such as Giemsa stain and Warthin-Starry stain, or
immunohistochemical stain) as the reference standard in this re-
view.
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Immunohistochemical stains are more accurate than special stains,
while special stains and immunohistochemical stains are thought
to have better specificity than H & E stains for diagnosis of H py-
lori infection (Laine 1997; Lee 2015b). For this reason,we consid-
ered endoscopic biopsy with histology using immunohistochem-
ical stain as the best reference standard, and endoscopic biopsy
with histology using H & E stain as the worst reference standard.
Search methods for identification of studies
We included all studies, irrespective of the language of publication
and publication status. If we found articles in languages other than
English, we obtained translations.
Electronic searches
We searched the following databases.
1. MEDLINE via OvidSP (January 1946 to 4 March 2016)
(Appendix 2).
2. Embase via OvidSP (January 1947 to 4 March 2016)
(Appendix 3).
3. Science Citation Index Expanded via Thomson Reuters
Web of Science (January 1980 to 4 March 2016) (Appendix 4).
4. National Institute for Health Research (NIHR HTA) via
Centre for Reviews and Dissemination, University of York. (
www.crd.york.ac.uk/CRDWeb/) (4 March 2016) (Appendix 5).
Searching other resources
To identify additional studies, we examined references in the in-
cluded studies to see if any might be relevant. We also searched for
articles related to the included studies by using the ’related search’
function inMEDLINE (OvidSP) and Embase (OvidSP).We con-
ducted a ’citing reference’ search (by searching articles which cited
the included articles) (Sampson 2008) in MEDLINE (OvidSP)
and Embase (OvidSP) on 4 December 2016.
Data collection and analysis
Selection of studies
Two review authors (KG and LB, SS, or AS) independently
searched the references to identify relevant studies. We obtained
the full text for references considered relevant by at least one of the
two review authors. Two review authors independently screened
the full-text papers against the inclusion criteria, resolving any dif-
ferences in study selection by discussion. We attempted to contact
study authors if there were doubts about the eligibility of a study.
Data extraction and management
Two review authors (KG and LB, SS, or AS) independently ex-
tracted the following data from each included study, using a pre-
piloted data extraction form, and resolving differences by discus-
sion.
1. First author.
2. Year of publication.
3. Study design (prospective or retrospective cohort studies;
cross-sectional studies or randomised controlled trials).
4. Inclusion and exclusion criteria for individual studies.
5. Total number of participants.
6. Number of female participants.
7. Average age of the participants.
8. Initial testing versus testing after eradication.
9. Number of people with bleeding ulcers, gastric atrophy,
lymphoma, and recent or current use of proton pump inhibitors
or antibiotics.
10. Number of symptomatic participants.
11. Tests carried out prior to the index test.
12. Description of the index test.
13. Threshold used for the index test.
14. Reference standard.
15. Number of true positives, false positives, false negatives,
and true negatives (i.e. 2 x 2 data) at each threshold reported.
If a study reported multiple index tests, we extracted the 2 x 2 data
for each index test at each threshold. For studies that reported test
accuracy for different reference standards, we extracted 2 x 2 data
for only one of the reference standards. For this purpose, due to
the accuracy of the stains, we preferred the immunohistochemical
stain over special stains, which in turn we preferred over the H &
E stain.
Although the number of uninterpretable index test results may
provide information on the applicability of the tests in clinical
practice and may affect the cost effectiveness of a test, we had
planned to exclude patients with uninterpretable index test results
from the meta-analyses. We made this decision because in clinical
practice uninterpretable index test results would result in addi-
tional testing. Nevertheless, we would have extracted and reported
such data if available from the studies.
If we suspected an overlap of participants betweenmultiple reports
due to common study authors and centres, we planned to contact
the study authors for clarification; however, this was not required,
since we could identify multiple reports of the same study using
the information provided in the reports. We sought further infor-
mation from study authors, if necessary.
Assessment of methodological quality
Two review authors independently assessed study quality using
the QUADAS-2 tool (Whiting 2006; Whiting 2011), resolving
differences by discussion. The criteria used for the assessment are
shown in Appendix 6. We considered studies classified as ’low risk
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of bias’ and ’low concern’ in all the domains of the QUADAS-2
tool as studies with high methodological quality. It must be noted
here that ’risk of bias’ refers to internal validity (i.e. whether there
were systematic errors in performing the study with respect to the
particular domain), while ’applicability concern’ refers to external
validity (i.e. whether there were concerns that the population,
index test or reference standard used in the studies matched the
review question).
Statistical analysis and data synthesis
We plotted study estimates of sensitivity and specificity on for-
est plots and in receiver operating characteristic (ROC) space
to explore between-study variation in the accuracy of each test.
We examined the thresholds reported for each test and the refer-
ence standards used. Due to between-study variation in thresh-
olds, we performed meta-analyses by using the hierarchical sum-
mary receiver operating characteristics (HSROC) model to esti-
mate SROC curves (Rutter 2001). For these analyses, if a study re-
ported test accuracy at multiple thresholds, we selected the thresh-
old used by the study authors for their primary analysis.
Prior to comparative meta-analyses of the tests, we performed
meta-analysis of each test separately for preliminary investigation
of the shape of the SROC curve of each test and to assess hetero-
geneity in test performance. We used this approach to understand
the data and to guidemodelling assumptions wemay need tomake
in the comparative meta-analysis. These preliminary analyses were
done noting the availability of comparative studies. To compare
the accuracy of the index tests, we added test type as a covariate
to the HSROCmodel (Macaskill 2013). For the indirect compar-
ison where we used all available data (i.e. not restricted to com-
parative studies), we assessed the effect of test type on the accu-
racy, threshold, and shape parameters of the HSROC model. We
also explored the effect of test type on the variance of the random
effects for accuracy and threshold. To determine the final meta-
analytic model, we used likelihood ratio tests to assess model fit.
Likelihood ratio tests were also used to determine the statistical
significance of differences in test accuracy. When SROC curves
are symmetric (i.e. HSROC model without the shape parameter),
each curve can be described using the diagnostic odds ratio (DOR)
to quantify the accuracy of the test. We used the ratio of DORs
as a summary of the relative accuracy of two tests.
Summary sensitivities and specificities can be obtained from a
HSROC model but they are not clinically interpretable here be-
cause we included studies with different thresholds. We therefore
estimated sensitivities at points on the SROC curves that corre-
spond to the lower quartile, median and upper quartile of the
specificities from the studies included in the meta-analysis. When
comparative studies that had evaluated two tests head-to-headwere
available, we performed direct comparisons of the tests (Takwoingi
2013). For these analyses, we fitted HSROC models with sym-
metric SROC curves, as the available data were insufficient for
reliable estimation of the shape of the SROC curves (Takwoingi
2017).
If there were at least two studies that reported the accuracy of a
test at the same threshold, we considered meta-analysis to obtain
summary estimates of sensitivity and specificity. Due to the small
number of studies in these analyses, we performed meta-analyses
using univariate fixed-effect or random-effects logistic regression
models, depending on the extent of heterogeneity observed in for-
est plots and in ROC space (Takwoingi 2017). When there were
only two or three studies at the same threshold, and little or no
heterogeneity observed in ROC space, we used univariate fixed-
effect logistic regression models to pool sensitivities and specifici-
ties separately. When there were two or three studies and we ob-
served heterogeneity, we did not perform meta-analysis, as ran-
dom-effects models would be more appropriate in such situations.
However, random effects cannot be reliably estimated with very
few studies.
We performed meta-analyses using the NLMIXED procedure in
SAS.
Investigations of heterogeneity
We used forest plots and scatter plots of sensitivity against speci-
ficity for preliminary investigation of potential sources of hetero-
geneity such as:
1. Type of reference standard (different histological stains).
2. Studies at low risk of bias in all the QUADAS-2 domains
versus those at unclear or high risk of bias.
3. Full-text publications versus abstracts (may provide insight
into publication bias if there is an association between the results
of a study and full publication of the study) (Eloubeidi 2001).
4. Prospective versus retrospective studies.
5. Symptomatic versus asymptomatic participants.
6. Recent or current use of proton pump inhibitors or
antibiotics, as these patients are at higher risk of false negative
results for the urea breath test and stool antigen test, with
serology being the only non-invasive test unaffected by the use of
proton pump inhibitors or antibiotics (Malfertheiner 2012;
Ricci 2007).
7. Different subtypes of tests (ELISA, latex agglutination test,
and Western blot methods of serological tests; formal serological
tests versus bedside serological tests; and monoclonal versus
polyclonal antibodies for stool antigen tests).
8. Interval between index test and reference standard.
Resolution of H pylori infection in people with H pylori infection
(usually with treatment) and infection in those without H pylori
infection may occur if there was a long interval between the
index test and reference standard.
We formally investigated heterogeneity for each test by adding a
covariate to a HSROC model (meta-regression). We used likeli-
hood ratio tests to assess the statistical significance of differences
in test accuracy by comparing models with and without the co-
variate.
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Sensitivity analyses
We planned to examine the impact of data inconsistencies on the
meta-analytic findings. For example, if test accuracy data reported
in the text of a paper differed from those in the figures, we planned
to assess the impact of using different data in sensitivity analyses;
however, we did not find such inconsistencies.
Assessment of reporting bias
Due to limited data, we were unable to formally investigate
whether test accuracy differed between studies that were published
as full texts and those available only as abstracts.
R E S U L T S
Results of the search
We identified 23,896 references through electronic searches of
MEDLINE, Embase, Science Citation Index, and NIHR HTA.
We did not identify additional references through other searches.
The flow of studies through the screening process is shown in
Figure 2. After removing 10,313 duplicates, there were 13,583 ref-
erences.Of these, we dropped11,737 irrelevant references through
reading the titles and abstracts. We could not obtain the full text of
11 references. The quality of copies of two references was too poor
to allow translation and we were unable to obtain better copies.
We assessed the full text of the remaining 1833 references. We
excluded 1728 references (1727 studies) for reasons stated in Ap-
pendix 7 (also see Characteristics of excluded studies below). The
remaining 107 references (101 studies) met our inclusion criteria.
Two references reported diagnostic accuracy data separately for
people who underwent gastrectomy and those who did not un-
dergo gastrectomy, and so we considered these subgroups as sep-
arate studies (Adamopoulos 2009a; Adamopoulos 2009b; Sheu
1998a; Sheu 1998b).
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Figure 2. Study flow diagram.
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Characteristics of included studies
We summarise the characteristics of the 101 included studies in
the Characteristics of included studies table. The studies included
11,003 participants, of which 5839 participants (53.1%) had H
pylori infection. The prevalence of H pylori infection ranged from
15.2% to 94.7% with a median of 53.7% (interquartile range:
42.0% to 66.5%).
Of the 101 studies, 34 evaluated urea breath test-13C; 21 evalu-
ated urea breath test-14C; two evaluated urea breath test but did
not report the isotope used; 34 evaluated serology; and 29 eval-
uated stool antigen test. Seventeen studies evaluated more than
one test. Of these, 15 evaluated two tests (Dede 2015; El-Din
2013; Eltumi 1999; Hafeez 2007; Inelmen 2004; Korstanje 2006;
Kuloglu 2008; Lahner 2004; Lottspeich 2007; Mansour-Ghanaei
2011; Ogata 2001; Soomro 2012; Vandenplas 1992; Yoshimura
2001; Yu 2001), and two evaluated three tests (Monteiro 2001a;
Salles-Montaudon 2002). Studies used different thresholds, with
15 studies reporting test accuracy at more than one threshold
(Chey 1998; Dede 2015; Delvin 1999; Formichella 2013; Ladas
2002a; Mana 2001a; Misawa 1998; Monteiro 2001a; Morales
1995; Noguera 1998; Novis 1991; Ozturk 2003; Trevisani 2005;
Weiss 1994; Yu 2001).
Eleven studies were prospective (Adamopoulos 2009a;
Adamopoulos 2009b; Al-Fadda 2000; Arikan 2004; Dede 2015;
Eltumi 1999; Fallone 1995; Kalach 1998a; Kuloglu 2008; Ogata
2001; Qadeer 2009); six studies were retrospective (Bosso 2000;
Czerwionka-Szaflarska 2007; Graham 1996a; Iqbal 2013; Mion
1994; Wardi 2012), while the remaining 84 studies did not state
whether they were prospective or retrospective studies. Six stud-
ies were published as abstracts only (Han 2012; Mohammadian
2007; Rathbone 1986; Sheu 1998a; Sheu 1998b; Thobani 1995),
and the remaining 95 were full-text publications.
Fourteen studies included only children (Argentieri 2007; Behrens
1999; Czerwionka-Szaflarska 2007; Delvin 1999; Dinler 1999;
Eltumi 1999; Hafeez 2007; Kalach 1998a; Kuloglu 2008;
Lottspeich 2007; Ogata 2001; Rafeey 2007; Vandenplas 1992;
Yoshimura 2001). Five studies clearly included only adults (Atli
2012; Chen 1991; Kamel 2011; Safe 1993; Salles-Montaudon
2002). Although not clearly specified in the remaining 82 studies,
it appeared that most or all of the participants were adults. The
mean or median age of the participants included in these stud-
ies ranged between 31 years and 85 years in the 45 studies that
reported this information. One study included only participants
without symptoms (Wang 2008). Fifty-eight studies included only
participants with symptoms, usually abdominal pain or dyspep-
sia (Adamopoulos 2009a; Adamopoulos 2009b; Aguilar 2007;
Al-Fadda 2000; Allardyce1997; Behrens1999; Bosso 2000;Ceken
2011; Chen 1991; Czerwionka-Szaflarska 2007; D’Elios 2000;
Delvin 1999; Dinler 1999; Ekesbo 2006; El-Din 2013; El-Mekki
2011; El-Nasr 2003; Eltumi 1999; Fanti 1999; Faruqui 2007;
Ferrara 1998; Germana 2001; Guo 2011; Gurbuz 2005; Hafeez
2007; Jordaan 2008; Kamel 2011; Kuloglu 2008; Ladas 2002a;
Lahner 2004; Lee 1998; Lottspeich 2007; Mansour-Ghanaei
2011; Mion 1994; Misawa 1998; Mohammadian 2007; Morales
1995; Novis 1991; Ogata 2001; Ozturk 2003; Peitz 2001; Qadeer
2009; Rafeey 2007; Rasool 2007; Rathbone 1986; Safe 1993;
Scuderi 2000; Segamwenge 2014; Selcukcan 2011; Sharbatdaran
2013; Sheu 1998a; Soomro 2012; Surveyor 1989; Thobani 1995;
Vandenplas 1992; Villalobos 1992;Weiss 1994; Yoshimura 2001).
The remaining 42 studies did not report the type of participants
included. Five studies included only participants who had previ-
ously undergone gastrectomy (Adamopoulos 2009b; Lombardo
2003; Schilling 2001; Sheu 1998b; Wardi 2012). Two stud-
ies included only participants with atrophic gastritis (Korstanje
2006; Ogata 2001). It was clear that participants who received
recent proton pump inhibitors or antibiotics were excluded from
53 studies (Ceken 2011; Chey 1998; Debongnie 1991; D’Elios
2000; Delvin 1999; Duan 1999; El-Mekki 2011; El-Nasr 2003;
Eltumi 1999; Fallone 1996; Fanti 1999; Ferrara 1998; Formichella
2013; Germana 2001; Guo 2011; Gurbuz 2005; Jekarl 2013;
Jensen 1998; Jordaan 2008; Kalach 1998a; Kim 2016; Kuloglu
2008; Ladas 2002a; Lahner 2004; Lee 1998; Lombardo 2003;
Lottspeich 2007;Mana 2001a;Mansour-Ghanaei 2011;Monteiro
2001a;Ogata 2001;Ozturk 2003; Peitz 2001; Peura 1996; Puspok
1999; Qadeer 2009; Rafeey 2007; Rasool 2007; Schilling 2001;
Segamwenge 2014; Selcukcan 2011; Sharbatdaran 2013; Shin
2009; Tiwari 2014; Trevisani 2005; Vandenplas 1992; Villalobos
1992; Wang 2008; Weiss 1994; Yan 2003; Yoshimura 2001; Yu
1999; Yu 2001). It was not clear whether such participants were
included or excluded in the remaining 48 studies.
Thirty-two studies used H & E stain as a reference stan-
dard (Aguilar 2007; Al-Fadda 2000; Arikan 2004; Atli 2012;
Behrens 1999; Ceken 2011; Chen 1991; Chey 1998; Czerwionka-
Szaflarska 2007; D’Elios 2000;Dinler 1999; Eggers 1990; El-Nasr
2003; Fallone 1996; Faruqui 2007; Graham 1996a; Gramley
1999; Gurbuz 2005; Iqbal 2013; Jordaan 2008; Kalach 1998a;
Kamel 2011; Lee 1998; Logan 1991a; Noguera 1998; Puspok
1999; Segamwenge 2014; Selcukcan 2011; Sheu 1998a; Sheu
1998b; Tiwari 2014; Yu 2001); 24 studies used special stains such
as Warthin-Starry stain, Giemsa stain, or silver stain (Argentieri
2007; Bosso 2000; El-Din 2013; Fallone 1995; Guo 2011; Hafeez
2007; Han 2012; Ivanova 2010; Kim 2016; Ladas 2002a; Lahner
2004; Mion 1994; Mohammadian 2007; Morales 1995; Novis
1991; Ozturk 2003; Peura 1996; Qadeer 2009; Schilling 2001;
Scuderi 2000; Shin 2009; Soomro 2012; Villalobos 1992; Yan
2003); two studies used immunohistochemical staining (Ekesbo
2006; Misawa 1998); and the remaining 43 studies used a com-
bination of different stains.
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The interval between the index test and reference standard was
reported only in 21 studies. The interval was less than two weeks
in 19 of the 21 studies (Adamopoulos 2009a; Adamopoulos
2009b; Bosso 2000; Debongnie 1991; Duan 1999; Fallone
1995; Fallone 1996; Formichella 2013; Gurbuz 2005; Hafeez
2007; Lahner 2004; Lee 1998; Logan 1991a; Lottspeich 2007;
Mansour-Ghanaei 2011; Mion 1994; Ozturk 2003; Peura 1996;
Safe 1993), and was between 15 days and 23 days in one study
(Dede 2015); it was within 30 days in the remaining study
(Lombardo 2003).
Characteristics of excluded studies
We excluded 1726 references (1725 studies). The reason for ex-
clusion is stated for each study in Appendix 7 and summarised
below.
• Case-control study: 17
• Not a primary research study: 147
• Erratum: 3
• Inappropriate population: 79
◦ In monitoring: 33
◦ Not in humans: 1
◦ Only in H pylori negative people: 2
◦ Only in H pylori positive people: 39
◦ Only in people with gastrointestinal bleeding: 2
◦ Selection of participants was based on the results of
other H pylori tests: 1
◦ Includes people who were being monitored for H
pylori status: 1
• Inappropriate index test: 38
• Inappropriate target condition: 4
• Inappropriate reference standards: 1182
• Lack of data: 256
◦ Insufficient diagnostic test accuracy data: 25
◦ No diagnostic accuracy data: 42
◦ Not a diagnostic test accuracy study of non-invasive H
pylori diagnosis: 188
◦ Incorrect data (correct information could not be
obtained): 1
Methodological quality of included studies
The methodological quality of the included studies is summarised
across all studies in Figure 3. None of the included studies was
of high methodological quality (i.e. low risk of bias in all the
domains). Appendix 8 shows the results for individual studies for
urea breath test-13C, urea breath test-14C, serology and the stool
antigen test, respectively.
Figure 3. Risk of bias and applicability concerns graph: review authors’ judgements about each domain
presented as percentages across included studies. For each domain, the numbers shown on the bar represent
the number of studies that were scored as high, unclear or low in terms of risk of bias or applicability concern.
Patient selection domain
In the patient selection domain, 23, 15 and 63 studies were at
low, high and unclear risk of bias, respectively. All 15 studies were
at high risk of bias because they did not include a consecutive or
random series of participants.
Twenty-five, seven and 69 studies were of low, high and unclear
applicability concern. In the 69 studies of unclear applicability
concern it was not clear whether participants similar to those seen
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in the clinical settingwhere the test is usedwere excluded, while the
seven studies of high concern clearly excluded such participants. In
these seven studies, only people who had undergone gastrectomy
or those with atrophic gastritis were included.
Index test domain
In the index test domain, studies generally had an unclear risk
of bias because it was unclear whether the index test results were
interpreted without the knowledge of the results of the reference
standard, and/or it was unclear whether a threshold was prespeci-
fied.
Urea breath test
None of the studies that evaluated the urea breath test (13C, 14C,
or unknown isotope) were at low risk of bias. The risk of bias was
unclear in the two studies that did not report the type of isotope
(Han 2012; Lombardo 2003). Of the 34 studies that evaluated
urea breath test-13C, seven (21%) had a high risk of bias while
27 (79%) had unclear risk of bias. There were 21 studies of urea
breath test-14C, 16 (76%) of which had unclear risk of bias while
five (24%) had high risk of bias.
For the two studies with unknown isotope, applicability concern
was high in one study and low in the other. Of the 34 urea breath
test-13C studies, applicability concerns were unclear for two (6%)
studies, high for six (18%) studies and low for 26 (76%) studies.
For urea breath test-14C, applicability concerns were generally low
(18/21; 86%) with only three studies having high applicability
concerns (Selcukcan 2011; Surveyor 1989; Yu 1999) .
Serology
One study (Ladas 2002a), had a low risk of bias.and another study
(Rathbone 1986), had a high risk of bias. The risk of bias for the
remaining 32 (94%) studies was unclear. Applicability concerns
were low in 19 (56%) studies and high in 15 (44%) studies.
Stool antigen test
None of the 29 studies had a high risk of bias. Most of the studies
(26/29; 90%) had an unclear risk of bias; three studies (Islam
2005; Kuloglu 2008; Sharbatdaran 2013), had a low risk of bias.
All the studies were of low applicability concern.
Reference standard domain
Two studies were at low risk of bias in the reference standard
domain (Fallone 1995; Ladas 2002a). For 27 studies, the risk of
biaswas unclear because itwas not clearwhether reference standard
results were interpreted without knowledge of the results of the
index tests. The remaining 72 studies were at high risk of bias
because the reference standard was endoscopic biopsy with H &
E stain in some or all participants.
All the studies were of low applicability concern.
Flow and timing domain
Seven studies were at low risk of bias in the flow and timing do-
main. The risk of bias was unclear for 74 studies because the inter-
val between the index test and reference standard was unclear or it
was unclear whether all participants were included in the analysis.
The remaining 20 studies were at high risk of bias because some
participants were clearly excluded from the analysis. These studies
did not report the reference standard results for the excluded par-
ticipants. None of the studies reported indeterminate results (i.e.
there were no indeterminate index test results in studies which
provided a clear participant flow and none of the exclusions were
due to indeterminate index test results).
Findings
Urea breath test-13C
The 34 studies of urea breath test-13C included 3139 participants,
of whom 1526 had H pylori infection (Figure 4). The threshold
used in six studies was either unknown (Eggers 1990; Monteiro
2001a), or unclear (Sheu 1998a; Sheu 1998b; Vandenplas 1992;
Wardi 2012). At the most commonly reported threshold of delta
over baseline > 4% (30 minutes after administration of urea), the
summary sensitivity (95%confidence interval (CI)) and specificity
(95% CI) from 10 studies (958 participants) were 0.95 (95% CI
0.79 to 0.99) and 0.95 (95% CI 0.87 to 0.98). Other thresholds
were used by a limited number of studies (Figure 5; Appendix 9).
When possible we performed meta-analysis to estimate summary
sensitivities and specificities at these common thresholds. The re-
sults are presented in Table 1.
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Figure 4. Forest plot of urea breath test-13C.FN = false negative; FP = false positive; TN = true negative; TP
= true positive. The forest plot shows an estimate of sensitivity and specificity from each study and the
threshold used. Studies are sorted by threshold, sensitivity and specificity. For threshold, the number of
minutes in brackets is the time after administration of urea.
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Figure 5. Forest plot of urea breath test-13C at commonly reported thresholds. FN = false negative; FP =
false positive; TN = true negative; TP = true positive. Thresholds are shown in brackets and the number of
minutes in brackets is the time after administration of urea.
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Urea breath test-14C
Figure 6 shows the 21 studies of urea breath test-14C. The studies
included 1810 participants (involving 1018H pylori cases). Three
studies did not state the thresholds used (Selcukcan 2011; Surveyor
1989; Yu 1999). The two most commonly used thresholds were
counts per minute > 50 (10 minutes after administration of urea)
in six studies (471 participants) and disintegrations per minute
> 200 (10 minutes) in four studies (296 participants) (Table 1).
Test accuracy results for other thresholds are shown in Appendix
9. The summary sensitivity (95% CI) and specificity (95% CI) at
the counts per minute > 50 threshold were 0.89 (95% CI 0.55 to
0.98) and 0.91 (95% CI 0.79 to 0.96). For the disintegrations per
minute > 200 threshold, the summary sensitivity (95% CI) and
specificity (95% CI) were 0.95 (95% CI 0.33 to 1.00) and 0.95
(95% CI 0.80 to 0.99).
Figure 6. Forest plot of urea breath test-14C. FN = false negative; FP = false positive; TN = true negative;
TP = true positive. The forest plot shows an estimate of sensitivity and specificity from each study and the
threshold used. Studies are sorted by threshold, sensitivity and specificity. For threshold, the number of
minutes in brackets is the time after administration of urea.
Serology
Serology was evaluated in 34 studies with a total of 4242 partic-
ipants, of whom 2477 had H pylori infection (Figure 7). There
was considerable variation in the thresholds used but 14 (41%)
studies did not state the thresholds used. A threshold of > 7 units/
ml was used in two studies (Iqbal 2013; Ogata 2001), involving
97 participants, and two studies involving 234 participants (Ladas
2002a; Monteiro 2001a) used a threshold of ≥ 300 units (Table
1). The summary sensitivity (95% CI) and specificity (95% CI)
at the > 7 units/mL threshold were 0.98 (95% CI 0.74 to 1.00)
and 0.71 (95% CI 0.51 to 0.86), and 0.91 (95% CI 0.82 to 0.96)
and 0.86 (95% CI 0.72 to 0.93) for the ≥ 300 units threshold.
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Figure 7. Forest plot of serology. FN = false negative; FP = false positive; SD = standard deviation; TN = true
negative; TP = true positive. The forest plot shows an estimate of sensitivity and specificity from each study
and the threshold used. Studies are sorted by threshold, sensitivity and specificity. Other threshold is staining
of a 120kDa protein (CagA) gel band and/or at least two of five proteins between 28-33 kDa.
Stool antigen test
Twenty-nine studies assessed the stool antigen test in 2988 partic-
ipants (including 1311 H pylori cases) (Figure 8). The threshold
used was unknown in almost half of the studies (14/29, 48%).
None of the thresholds reportedwere used bymore than one study.
Summary estimates of sensitivity and specificity were therefore not
obtained at a common threshold.
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Figure 8. Forest plot of stool antigen test. FN = false negative; FP = false positive; TN = true negative; TP =
true positive; WL = wavelength. The forest plot shows an estimate of sensitivity and specificity from each
study and the threshold used. Studies are sorted by threshold, sensitivity and specificity.
Comparative accuracy of non-invasive tests for H
pylori infection
Comparison based on all studies (Indirect test comparison)
Across the four tests (urea breath test-13C, urea breath test-14C,
serology and stool antigen test) 99 studies (5694 cases; 10799 par-
ticipants) were included in this comparative meta-analysis (Figure
9). Preliminary assessment of each test separately indicated there
was no significant association between test accuracy and threshold,
and so a symmetric SROC curve is plausible for each test. Based
on these preliminary assessments, and likelihood ratio tests com-
paring different HSROC meta-regression models with covariate
terms for test type and examination of the variance parameters in
these models, the final model we fitted allowed for differences in
accuracy and threshold as random effects (i.e. unequal variances
for the random effects) with symmetric SROC curves for the tests.
Overall, there was statistical evidence of a difference in accuracy
(P = 0.024). The DORs (95% CI) for urea breath test-13C, urea
breath test-14C, serology and stool antigen test were 153 (95%
CI 73.7 to 316), 105 (95% CI 74.0 to 150), 47.4 (95% CI 25.5
to 88.1) and 45.1 (95% CI 24.2 to 84.1) respectively (Table 2).
The accuracy of urea breath tests (13C and 14C) was significantly
higher than that of serology and stool antigen test. For example,
the ratio of DORs (95%) for urea breath test-13C compared to
serology was 3.22 (95% CI 1.24 to 8.37), P = 0.017.
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Figure 9. Summary ROC plot of non-invasive tests for H pylori infection. The SROC curves for the four
tests are parallel. The curve for each test is drawn within the range of estimates of specificity from the studies
included for the test.
19Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 3 shows the clinical implications of using each of the four
tests in a hypothetical cohort of 1000 people with different levels
of prevalence ofHpylori infection. For example, given a prevalence
of 53.7% and a specificity of 0.90, 46 people who do not have
H pylori infection will be treated and urea breath test-13C, urea
breath test-14C, serology and stool antigen test will miss 30, 42,
86 and 89 people respectively who have H pylori infection.
Direct comparisons (restricted to comparative studies)
Direct comparisons were based on few studies. Table 4 shows the
number of studies (N) for each pairwise comparison and, where
meta-analysis was possible, the ratio of DORs with 95% CIs and
P value. There were no comparative studies of urea breath test-
13C and urea breath test-14C. All other comparisons were based on
seven or fewer studies. Each pair of tests were evaluated as follows:
• Urea breath test-13C versus serology (Figure 10): seven
studies (Eltumi 1999; Korstanje 2006; Monteiro 2001a; Ogata
2001; Salles-Montaudon 2002; Vandenplas 1992; Yoshimura
2001).
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Figure 10. Summary ROC plot of direct comparisons of urea breath test-13C and serology. Each summary
curve was drawn restricted to the range of specificities for each test. The size of each symbol was scaled
according to the precision of sensitivity and specificity in the study. A dotted line joins the pair of points for the
two tests from each study.
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• Urea breath test-13C versus stool antigen test (Figure 11):
seven studies (Hafeez 2007; Inelmen 2004; Lahner 2004;
Lottspeich 2007; Monteiro 2001a; Salles-Montaudon 2002; Yu
2001).
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Figure 11. Summary ROC plot of direct comparisons of urea breath test-13C and stool antigen test. Each
summary curve was drawn restricted to the range of specificities for each test. The size of each symbol was
scaled according to the precision of sensitivity and specificity in the study. A dotted line joins the pair of points
for the two tests from each study.
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• Urea breath test-14C versus serology: two studies (Dede
2015; Kuloglu 2008).
• Urea breath test-14C versus serology: one study
(Mansour-Ghanaei 2011).
• Serology versus stool antigen test: four studies (El-Din
2013; Monteiro 2001a; Salles-Montaudon 2002; Soomro 2012).
The ratios of DORs (95% CI; P value) were 0.68 (95% CI 0.12
to 3.70; P = 0.56) for urea breath test-13C versus serology, and
0.88 (95% CI 0.14 to 5.56; P = 0.84) for urea breath test-13C
versus stool antigen test. Due to paucity of data and substantial
heterogeneity observed in ROC space which precluded the use of
simpler meta-analytic models, meta-analyses were not possible for
the other two test comparisons that had more than one study. For
the single study of urea breath test-14C versus serology (Mansour-
Ghanaei 2011), both tests had similar sensitivity, but specificity
was higher for urea breath test-14C than for serology.
Investigation of heterogeneity
We were unable to investigate subtype of tests because most of the
serological tests were ELISA (17/20 (85%) studies that provided
the type of serology test) and most studies (24/29 (83%) studies)
did not report whether monoclonal or polyclonal antibodies were
used for stool antigen tests. Studies did not report the precise in-
terval between index test and reference standard (unless they were
performed on the same day), i.e. many studies did not report the
interval at all, while some reported that the tests were performed
within a few days of each other without stating the exact time in-
terval. Of those that reported the interval, only two studies had an
interval of more than two weeks (Dede 2015; Lombardo 2003).
For each of the four tests, Appendix 10 shows the number of stud-
ies in each subgroup of other factors we had planned to investigate.
Given the availability of data, we were only able to perform meta-
regression to investigate the effect of reference standard on the ac-
curacy of each test. Of the 99 studies, 42 (42%) used a combina-
tion of stains and there were few data for Immunohistochemical
stains (2/99; 2%). The analyses were therefore limited to compar-
isons of H & E stain versus special stain for each test (Appendix
11). Although the effect of reference standard was not consistent
across tests, there was no statistical evidence of a difference in test
accuracy for any of the tests. For urea breath test-14C, the DOR
for special stain was higher than for H & E stain, while for the
other tests the DOR of both types of stain were similar or higher
for H & E (Appendix 11).
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Summary of findings
What is the best non-invasive test for diagnosis of H pylori infect ion?
Population Children and adults with gastrointest inal symptoms
Setting Primary care sett ing
Index tests Urea breath test-13C, Urea breath test-14C, serology, and stool ant igen test
Threshold Various thresholds were used for each test
Role and purpose of test Screening and diagnosis of H pylori
Reference standard Endoscopic biopsy with Haemotoxylin & Eosin stain, special stains, or combinat ion of Haemotoxylin & Eosin and special stains
Quality of evidence Risk of bias was generally high or unclear with respect to the select ion of part icipants, and the conduct and interpretat ion of the index tests
and reference standard. Applicability concerns were also generally high or unclear with respect to select ion of part icipants
Limitations There was heterogeneity in thresholds and reference standards. Studies did not of ten prespecif y or clearly report thresholds used
Pre- test probability (prevalence
of Helicobacter pylori)
Median (interquart ile range) = 53.7% (42.0% to 66.5%)
Index test Number of participants (studies) Diagnostic odds ratio (95% CI) Sensitivity (95%CI) at fixed speci-
ficity of 0.901
Missed H pylori cases per 1000
people tested (95% CI)2
Urea breath test-13C 3139 part icipants
(34 studies)
153 (95%CI 73.7 to 316) 0.94 (0.89 to 0.97) 30 (15 to 58)
Urea breath test-14C 1810 part icipants
(21 studies)
105 (95%CI 74.0 to 150) 0.92 (0.89 to 0.94) 42 (30 to 58)
Serology 4242 part icipants
(34 studies)
47.4 (95%CI 25.5 to 88.1) 0.84 (0.74 to 0.91) 86 (50 to 140)
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Stool ant igen test 2988 part icipants
(29 studies)
45.1 (95%CI 24.2 to 84.1) 0.83 (0.73 to 0.90) 89 (52 to 146)
Comparison of non- invasive tests for H pylori infection
Based on an indirect comparison of the four tests using all the studies, there was stat ist ical evidence of a dif ference in diagnost ic accuracy (P = 0.024). Direct comparisons
were based on few head-to-head studies. The rat ios of diagnost ic odds rat ios (95%CI; P value) were 0.68 (95%CI 0.12 to 3.70; P = 0.56) for urea breath test-13C versus serology
(seven studies), and 0.88 (95% CI 0.14 to 5.56; P = 0.84) for urea breath test-13C versus stool ant igen test (seven studies). The 95% conf idence intervals of these est imates
overlap with those of the rat ios of diagnost ic odds rat ios f rom the indirect comparison. Data were lim ited or unavailable for meta-analysis of other direct comparisons
Conclusions
In people with no history of gastrectomy and those who have not recent ly had ant ibiot ics or proton pump inhibitors, urea breath tests had high diagnost ic accuracy while
serology and stool ant igen tests had lower accuracy to detect H pylori infect ion. Although suscept ible to bias due to confounding, this conclusion is based on evidence
f rom indirect test comparisons as evidence f rom direct comparisons was based on few studies or was unavailable. It should be noted that studies were generally of poor
methodological quality. The thresholds used for the tests were highly variable and there is current ly insuf f icient evidence to recommend specif ic thresholds for use in clinical
pract ice
1The sensit ivit ies were est imated along the SROC curves at the median specif icity across the studies included for the four
tests.
2Based on the sensit ivity est imated at the median specif icity of 0.90, and the median prevalence of 53.7% f rom the included
studies, the numbers of m issed H pylori cases were calculated using a hypothet ical cohort of 1000 people suspected of having
H pylori infect ion. The 95% CI for the number of m issed cases is f rom the 95% CI for sensit ivity. For a specif icity of 0.90 and
prevalence of 53.7%, there will be 46 false posit ives. See Table 3 for results for other values of specif icity and prevalence.
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D I S C U S S I O N
Summary of main results
We included 101 studies (11,003 participants) that evaluated the
diagnostic accuracy of different non-invasive methods for the di-
agnosis of H pylori. Of these 11,003 participants, 5839 partici-
pants (53.1%) had H pylori infection. The prevalence of H pylori
infection ranged from 15.2% to 94.7%. The median prevalence
was 53.7% (lower quartile: 42.0% and upper quartile: 66.5%).
The summary of results for urea breath test-13C, urea breath
test-14C, serology and stool antigen test is given in Summary of
findings. The studies used different thresholds and reference stan-
dards. As a result, there were few data for pooling sensitivities
and specificities at specific thresholds, and we mainly estimated
and compared SROC curves. The test comparison based on all
available data (99 studies) for the four tests showed a statistically
significant difference in diagnostic accuracy between the test (P =
0.024). There was no statistical evidence of a difference in diag-
nostic accuracy between urea breath test-13C and urea breath test-
14C, while serology and stool antigen test were inferior to both
urea breath tests. Direct comparisons are more reliable than indi-
rect comparisons, due to the potential for confounding in indirect
comparisons (Takwoingi 2013). However, we found few head-to-
head studies and meta-analysis was possible for only two pairwise
comparisons (urea breath test-13C versus serology, seven studies;
and urea breath test-13C versus stool antigen test, seven studies).
Most of the tests that used visual assessment (for example, appear-
ance of a pink-red line) were stool antigen tests, although some
serology tests also used visual assessment. Some serology and stool
antigen tests are therefore easy to use (stool antigen test is easier
to use as described below), but low diagnostic accuracy is a dis-
advantage when compared to urea breath tests. Urea breath test
is a cumbersome test and involves the use of radioisotopes; how-
ever, urea breath test-13C may be the most accurate test among
the non-invasive tests. This has implications in the screening of
individuals for H pylori as a decision has to be made regarding
the use of a cumbersome and relatively costly test but with good
diagnostic accuracy versus cheap tests that can be performed easily
but with lower diagnostic accuracy. A further decision to make
if one opts for easy-to-use tests is the threshold at which the test
should be used. For example, one can use a threshold that pro-
vides higher sensitivity (at the cost of lower specificity, necessitat-
ing endoscopic biopsy confirmation or treatment) or a threshold
that provides higher specificity (at the cost of lower sensitivity,
resulting in people with H pylori not being treated). Although at
first sight it appears that the treatment for H pylori is relatively
harmless and one would prefer a threshold at which the test has
higher sensitivity rather than higher specificity, the decision to give
antibiotics is not a straightforward one, because of the association
between unnecessary antibiotic use and development of antimi-
crobial resistance (Llor 2014). Serology and stool antigen test have
similar diagnostic test accuracy and the choice between the two
may be made based on ease of carrying out the tests. Only one
study included in this review used whole blood for performing
serology (Chey 1998). Even this test required a laboratory techni-
cian to interpret the test result (Chey 1998). So, there are no bed-
side tests available for serology testing. On the other hand, bed-
side kits with easy interpretation by colour changes are available
for stool antigen tests, making them easy to administer (Inelmen
2004; Jekarl 2013; Kuloglu 2008; Qadeer 2009; Trevisani 2005).
A cost-effectiveness study may clarify the most cost-effective non-
invasive test in people with suspectedH pylori, but it is difficult to
factor in the price of antimicrobial resistance to an individual as
the price of antimicrobial resistance is paid by future generations
(through increased mortality and decreased productivity), rather
than the individual for whom the treatment decision has to be
made (Taylor 2014).
Strengths and weaknesses of the review
We conducted a thorough literature search and included full-
text publications and abstracts without any language restrictions.
There are currently no reliable search strategies to identify diag-
nostic test accuracy studies (Beynon 2013).We did not use any di-
agnostic filter in our search strategy, thereby ensuring that studies
on the topic were identified. Two review authors independently
identified and extracted data from the studies, potentially decreas-
ing errors related to single data extraction. PCR methodology is
not standardised across laboratories and it is an unreliable refer-
ence standard (Chey 2007). Endoscopic biopsy followed by rapid
urease testing has poor sensitivity following treatment with pro-
ton pump inhibitors, and endoscopic biopsy with culture has high
specificity but poor sensitivity (Chey 2007). We used a strict ref-
erence standard (histology) which is likely to diagnose the target
condition with a high degree of accuracy. These are the major
strengths of the review.
Amajor limitation was the diversity of thresholds used in the stud-
ies. As a result, data were sparse for each threshold, which limited
estimation of summary sensitivities and specificities. Therefore
there is insufficient evidence to recommend specific thresholds for
each of the tests. Nonetheless, we were able to estimate and com-
pare SROC curves by including studies with different thresholds.
There was a high proportion of studies at high risk of bias and with
high concern regarding applicability in all the four domains of the
QUADAS-2 tool. This makes the validity and applicability of the
results questionable. The major concerns were lack of reporting
of the threshold used or when the thresholds were reported, there
was no information to judge whether the thresholds were prespec-
ified. Despite the lack of statistical evidence of an effect of type of
reference standard on test accuracy, as there were few studies for
each subgroup and other differences between studies, we cannot
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conclude that diagnostic accuracy does not depend on type of ref-
erence standard.
Comparison with other systematic reviews
We identified several relevant systematic reviews (Ferwana 2015;
Gisbert 2001; Gisbert 2004a; Loy 1996; Zhou 2014; Zhou 2017).
The findings from this review support those of Zhou 2017, and
Ferwana 2015, that urea breath test has high diagnostic accuracy
and that there was significant heterogeneity in the diagnostic ac-
curacy of the urea breath test (Zhou 2017). Our findings agree
with those of Zhou 2014 that stool antigen test has only modest
diagnostic test accuracy. The review findings are contrary to those
of Gisbert 2001, and Gisbert 2004a, which suggested that stool
antigen tests are highly accurate. This difference may be due to
the strict reference standards that we used in this review and how
we handled the issue of heterogeneity in thresholds. In agreement
with the findings of Loy 1996, the role of serology in clinical prac-
tice is uncertain, as stool antigen tests provide equivalent diagnos-
tic accuracy to serology and are easier to interpret.
Applicability of findings to the review question
This review included adults and children who underwent non-
invasive tests for the diagnosis of H pylori. Most of the studies
included only symptomatic people and so the findings of this
review are applicable only to people with symptoms. Most studies
excluded people who had previous gastrectomy and those who had
recent antibiotics or proton pump inhibitors. Hence, the findings
of this review are not applicable in these populations.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
In people with no history of gastrectomy and those who have not
recently had antibiotics or proton pump inhibitors, urea breath
tests had high diagnostic accuracy while serology and stool antigen
tests had lower accuracy to detect H pylori infection. Although
susceptible to bias due to confounding, this conclusion is based on
evidence from indirect test comparisons, as evidence from direct
comparisons was based on few studies or was unavailable. There
was high or unclear risk of bias for many studies with respect to the
selection of participants, and the conduct and interpretation of the
index tests and reference standard. The thresholds used for these
tests were highly variable, thus there is insufficient evidence to
identify specific thresholds thatmight be useful in clinical practice.
Implications for research
Further comparative studies of high methodological quality are
necessary to obtain more reliable evidence of accuracy between
the tests (urea breath tests, serology, and stool antigen tests) in
people with upper gastrointestinal symptoms and people without
any symptoms suggestive of H pylori. Such studies should be con-
ducted prospectively in a representative spectrum of participants,
and be clearly reported to ensure low risk of bias. Most impor-
tantly, studies should pre-specify and clearly report the thresholds
used, should apply appropriate reference standards such as endo-
scopic biopsy with special stains, and should avoid inappropriate
exclusions.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Adamopoulos 2009a
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 73
Female: 24 (33%)
Age: 63 years
Presentation:
1. People who had undergone endoscopy (for various indications)
Setting: secondary care, Greece
Index tests Index test: urea breath test -13C
Further details:
Technical specifications: manufacturer - Infai Institut für Biomedizinische; Analytik & NMR-
Imaging GmbH, Bochum
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and histopathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
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Adamopoulos 2009a (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
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Adamopoulos 2009b
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 31
Female: 8 (25.8%)
Age: 71 years
Presentation:
1. People who had undergone Billroth II gastrectomy and endoscopy (for various indications)
Setting: secondary, Greece
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: manufacturer - Infai Institut für Biomedizinische; Analytik & NMR-
Imaging GmbH, Bochum
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and histopathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low High
123Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Adamopoulos 2009b (Continued)
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Aguilar 2007
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 31
Female: 5 (16.1%)
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Aguilar 2007 (Continued)
Age: not stated
Presentation:
1. Dyspepsia
Setting: secondary care, Peru
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: Not stated
Performed by: Not stated
Criteria for positive diagnosis: disintegrations per minute > 200 (10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: Not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Low
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Aguilar 2007 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Al-Fadda 2000
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 64
Female: not stated
Age: not stated
Presentation:
1. Patients with upper gastroinstestinal symptoms
Setting: secondary care, Peru
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Al-Fadda 2000 (Continued)
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: Not stated
Performed by: Not stated
Criteria for positive diagnosis: CO2 recovery > 0.55 (20 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: Not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Low
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
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Al-Fadda 2000 (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Allardyce 1997
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 63
Female: 26 (41.3%)
Age: not stated
Presentation:
1. Dyspepsia
Setting: secondary care, New Zealand
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: Not stated
Performed by: Not stated
Criteria for positive diagnosis: disintegrations per minute > 49 (time not stated)
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Allardyce 1997 (Continued)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: Not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Low
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
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Allardyce 1997 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Argentieri 2007
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 215
Female: not stated
Age: not stated
Presentation:
1. Children undergoing upper gastrointestinal endoscopy
Exclusion:
1. Recent H pylori treatment
Setting: secondary care, Italy
Index tests Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA
Performed by: Not stated
Criteria for positive diagnosis: Not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: Not stated
Performed by: endoscopist and pathologist
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Argentieri 2007 (Continued)
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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Argentieri 2007 (Continued)
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Arikan 2004
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion:
1. Malignancy
2. Taken antibiotics or proton pump inhibitors in last 2 weeks
Setting: secondary care, Turkey
Index tests Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA
Performed by: Not stated
Criteria for positive diagnosis: Not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: Not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
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Arikan 2004 (Continued)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
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Arikan 2004 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Atli 2012
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 57 (57%)
Age: 71 years
Presentation:
1. Patients with dyspepsia and symptoms or signs related to peptic ulcer > 65 years of age
Exclusion:
1. Patients who had taken antibiotics or anti-ulcer treatment in the past 2 weeks
2. Advanced dementia
3. Cerbrovascular disease
4. Advanced respiratory problems
5. Alarm symptoms for malignancy
Setting: secondary setting, Turkey
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: counts per minute > 50 (10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
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Atli 2012 (Continued)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
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Atli 2012 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Behrens 1999
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 252
Female: not stated
Age: not stated
Presentation:
1. Children (3 years to 18 years) with abdominal pain, nausea, or vomiting
Exclusion criteria:
1. Previous treatment with antibiotics or proton pump inhibitors
2. WBC < 3500/microlitre or platelets < 100,000/microlitre
Setting: secondary setting, Germany
Index tests Index test: urea breath test -13C
Further details:
Technical specifications: Promochem, Wesel
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 5.0% (30 minutes and 60 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
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Behrens 1999 (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Behrens 1999 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Bosso 2000
Study characteristics
Patient sampling Type of study: retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 95
Female: not stated
Age: not stated
Presentation:
1. Patients with upper abdominal symptoms
Exclusion:
1. Patients with previous gastric surgery
Setting: secondary care, France
Index tests Index test: urea breath test -13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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Bosso 2000 (Continued)
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
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Bosso 2000 (Continued)
Unclear
Ceken 2011
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 67 (67%)
Age: 48 years
Presentation:
1. Patients with dyspepsia
Exclusion:
1. Antibiotics or anti-ulcer treatment within last 4 weeks
2. Gastric surgery
Setting: secondary care, France
Index tests Index test: stool antigen test
Further details:
Technical specifications: Helicobacter Antigen Quick Castte
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Ceken 2011 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Chen 1991
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 96
Female: not stated
Age: not stated
Presentation:
1. Adult patients with dyspepsia
Setting: secondary care, China
Index tests Index test: serology
Further details:
Technical specifications: Pyloriset
Performed by: not stated
Criteria for positive diagnosis: presence of agglutination (within 3 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
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Chen 1991 (Continued)
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
Chey 1998
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
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Chey 1998 (Continued)
Patient characteristics and set-
ting
Sample size: 287
Female: 140 (48.8%)
Age: 53 years
Presentation:
1. People undergoing endoscopy
Exclusion:
1. Recent treatment for H pylori or anti-ulcer treatment
Setting: Variable settings, USA
Index tests Index test 1a: serology
Further details:
Technical specifications: HM-CAP (Enteric Products Inc.)
Performed by: not stated
Criteria for positive diagnosis: not stated
Index test 1b: serology (serum)
Further details:
Technical specifications: Hp Chek (Chem Trak)
Performed by: not stated
Criteria for positive diagnosis: 2 red lines
Index test 1c: serology (whole blood)
Further details: same as for index test 2
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
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Chey 1998 (Continued)
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
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Czerwionka-Szaflarska 2007
Study characteristics
Patient sampling Type of study: retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 66 (66%)
Age: 13 years
Presentation:
1. Children with gastrointestinal disorders
Setting: secondary care, Poland
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0 % (time not stated)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
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Czerwionka-Szaflarska 2007 (Continued)
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
D’Elios 2000
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 256
Female: not stated
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D’Elios 2000 (Continued)
Age: not stated
Presentation:
1. Patients with dyspepsia
Exlusion:
1. Gastric surgery
2. Recent treatment for ulcer or H pylori
3. Pulmonary failure
Setting: secondary care, Italy
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: AB Analitica
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-13C
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D’Elios 2000 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
Debongnie 1991
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with previous gastric surgery excluded
Patient characteristics and set-
ting
Sample size: 230
Female: not stated
Age: not stated
Presentation:
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Debongnie 1991 (Continued)
1. Patients referred for upper gastrointestinal surgery
Excluded:
1. Gastric surgery
2. Haematologic disease
3. Immunodeficiency
4. Gastric cancer
5. Recent treatment for ulcer or H pylori
6. Atrophic gastritis
Setting: secondary care, Belgium
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: specific activity > 0.3% (10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Cresyl Violet stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 27 (11.7%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Urea breath test-14C
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Debongnie 1991 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Dede 2015
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 30
Female: 8 (26.7%)
Age: 55 years
Presentation:
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Dede 2015 (Continued)
1. Patients who had undergone partial gastrectomy
Setting: secondary care, Turkey
Index tests Index test 1: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Index test 2: urea breath test-14C
Further details:
Technical specifications: Heliprobe System, Kibion AB
Performed by: not stated
Different criteria for positive diagnosis:
• Counts per minute > 23 (10 minutes)
• Counts per minute > 29 (30 minutes)
• Counts per minute > 35 (20 minutes)
• Counts per minute > 50 (10 minutes)
• Counts per minute > 50 (20 minutes)
• Counts per minute > 50 (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and modified Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
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Dede 2015 (Continued)
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
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Dede 2015 (Continued)
Were all patients included in the
analysis?
Unclear
High
Delvin 1999
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 79
Female: not stated
Age: not stated
Presentation:
1. Children with gastrointestinal symptoms
Exclusion:
1. Chilren with functional abdominal pain
2. Anti-ulcer or H pylori treatment in last 6 weeks
Setting: secondary care, Canada
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: Dia 13-Helico; Dianatec iso
Performed by: not stated
Different criteria for positive diagnosis:
• Delta over baseline > 2.0% (30 minutes)
• Delta over baseline > 2.5% (30 minutes)
• Delta over baseline > 3.0% (30 minutes)
• Delta over baseline > 3.5% (30 minutes)
• Delta over baseline > 4.0% (30 minutes)
• Delta over baseline > 4.5% (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
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Delvin 1999 (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Delvin 1999 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
Dinler 1999
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 77
Female: 48 (62.3%)
Age: 13 years
Presentation:
1. Children with recurrent abdominal pain
Setting: secondary care, Turkey
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Dinler 1999 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
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Dinler 1999 (Continued)
Unclear
Duan 1999
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 149
Female: 35 (23.5%)
Age: 44 years
Presentation:
1. Patients with gastritis or gastric ulcer
Exclusion:
1. Treatment with antibiotics or bismuth in the previous 2 months
2. Previous gastric surgery or gastric cancer
Setting: secondary care, China
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: Finniga, MAT-252, USA
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 5 per thousand (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Duan 1999 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Eggers 1990
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Setting: secondary care, Germany
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 8 (7.4%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
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Eggers 1990 (Continued)
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Ekesbo 2006
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with previous gastric surgery excluded
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Ekesbo 2006 (Continued)
Patient characteristics and set-
ting
Sample size: 126
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing gastroscopy for dyspepsia or gastrointestinal bleeding
Setting: primary care, Sweden
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: staining of a 120 kilodalton protein gel band and/or at least 2 of 5
proteins between 28 - 33 kilodaltons
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with immunostaining
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 40 (24.1%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Serology
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Ekesbo 2006 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
El-Din 2013
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients without pathologic data excluded
Patient characteristics and set-
ting
Sample size: 19
Female: 6 (31.6%)
Age: 47 years
Presentation:
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El-Din 2013 (Continued)
1. Patients with upper gastrointestinal disorders
Setting: secondary care, Egypt
Index tests Index test 1: serology
Further details:
Technical specifications: Ridascreen
Performed by: not stated
Criteria for positive diagnosis: not stated
Index test 2: stool antigen test
Further details:
Technical specifications: Immunodiagnostik AG
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 33 (63.5%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Stool Antigen Test
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El-Din 2013 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
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El-Mekki 2011
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 55
Female: 35 (63.6%)
Age: 37 years
Presentation:
1. Patients with dyspepsia
Setting: secondary care, Saudi Arabia
Index tests Index test: serology
Further details:
Technical specifications: HeliSAL TM serum
Performed by: not stated
Criteria for positive diagnosis: > 1 units/ml
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
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El-Mekki 2011 (Continued)
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
El-Nasr 2003
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 50
Female: 16 (32%)
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El-Nasr 2003 (Continued)
Age: 36 years
Presentation:
1. Patients with dyspepsia
Setting: secondary care, Egypt
Index tests Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA, Meridien Diagnostics
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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El-Nasr 2003 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Eltumi 1999
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 50
Female: 17 (34%)
Age: 11 years
Presentation:
1. Children referred for endoscopy
Exclusion:
1. Recent treatment for H pylori
Setting: Tertiary care, UK
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Eltumi 1999 (Continued)
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 5 units/ml (40 minutes)
Index test 2: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Eltumi 1999 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Epple 1997
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 126
Female: 70 (55.6%)
Age: 48 years
Presentation:
1. Patients undergoing routine endoscopy
Exclusion:
1. Gastric cancer
2. Previous gastric surgery
Setting: secondary care, Germany
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > Mean + 2 standard deviations above normal level (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
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Epple 1997 (Continued)
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Fallone 1995
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: consecutive patients
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Fallone 1995 (Continued)
Patient characteristics and set-
ting
Sample size: 50
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion
1. Conditions that would make gastric biopsy dangerous
2. Lactating
3. Pregnant or women of child-bearing potential who were not using adequate control
Setting: secondary care, Canada
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > 1.5% excretion (15 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Silver stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 4 (7.4%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
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Fallone 1995 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Fallone 1996
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 106
Female: 51 (48.1%)
Age: 54 years
Presentation:
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Fallone 1996 (Continued)
1. Patients undergoing endoscopy
Exclusion:
1. Recent treatment for H pylori
Setting: secondary care, Canada
Index tests Index test: serology
Further details:
Technical specifications: HeliSAL TM serum
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Fallone 1996 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Fanti 1999
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 84
Female: 45 (53.6%)
Age: 50 years
Presentation:
1. Patients with dyspepsia
2. Not on current treatment for H pylori or ulcers
Setting: secondary care, Italy
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Fanti 1999 (Continued)
Index tests Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA (Meridian Diagnostics)
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450/630 nm > 0.150
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
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Fanti 1999 (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Faruqui 2007
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 50
Female: 26 (52%)
Age: 36 years
Presentation:
1. Patients with dyspepsia despite anti-ulcer treatment
Exclusion:
1. Myocardial infarction in the last 6 months
2. Cardiac failure
3. Bleeding diathesis
Setting: secondary care, Pakistan
Index tests Index test: stool antigen test
Further details:
Technical specifications: not stated
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Faruqui 2007 (Continued)
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
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Faruqui 2007 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Ferrara 1998
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 56 (56%)
Age: not stated
Presentation:
1. Patients with dyspepsia
2. Not on current treatment for H pylori
Setting: secondary care, Italy
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
181Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ferrara 1998 (Continued)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
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Ferrara 1998 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Formichella 2013
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 500
Female: 263 (52.6%)
Age: 50 years
Presentation:
1. Patients undergoing routine endoscopy
Exclusion:
1. Undergone H pylori eradication therapy
2. Active immunosuppressive therapy
3. Suffering from malignant diseases
Setting: secondary care, Germany
Index tests Index test 1a: serology
Further details:
Technical specifications: recomWell ELISA (Mikrogen)
Performed by: not stated
Criteria for positive diagnosis: not stated
Index test 1b: serology
Further details:
Technical specifications: not stated
Performed by: not stated
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Formichella 2013 (Continued)
Criteria for positive diagnosis: 2 or more antigens
Index test 1c: serology
Further details:
Technical specifications: Immunoblot Helicobacter (Mikrogen)
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain, Warthin-Starry stain, and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
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Formichella 2013 (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Germana 2001
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 52 (52%)
Age: 51 years
Presentation:
1. Patients with dyspepsia
2. Not on current treatment for H pylori
Setting: secondary care, Italy
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: Wagner Analysen - Tecturik
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)
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Germana 2001 (Continued)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and immunohistochemical stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
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Germana 2001 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Graham 1996a
Study characteristics
Patient sampling Type of study: retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 75
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing screening for H pylori and who underwent endoscopy
Setting: secondary care, USA
Index tests Index test: serology
Further details:
Technical specifications: FlexSure HP
Performed by: not stated
Criteria for positive diagnosis: pink line
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
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Graham 1996a (Continued)
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 476 (86.4%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
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Graham 1996a (Continued)
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Gramley 1999
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 22
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Setting: secondary care, USA
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
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Gramley 1999 (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Gramley 1999 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
Guo 2011
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 328
Female: 90 (27.4%)
Age: 47 years
Presentation:
1. Patients with gastrointestinal symptoms
2. No previous treatment or stopped treatment for H pylori
Setting: secondary care, China
Index tests Index test: stool antigen test
Further details:
Technical specifications: Kyowa pharmaceutical
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with silver stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Guo 2011 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Gurbuz 2005
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with previous gastric surgery excluded
Patient characteristics and set-
ting
Sample size: 65
Female: 45 (69.2%)
Age: not stated
Presentation:
1. Patients undergoing routine endoscopy
Exclusion:
1. Undergone H pylori eradication therapy
2. Pregnancy or lactation
3. Prior gastric surgery
Setting: secondary care, Turkey
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: Heliprobe system
Performed by: not stated
Criteria for positive diagnosis: Counts per minute > 50 (10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 3 (4.4%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
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Gurbuz 2005 (Continued)
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
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Hafeez 2007
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with inadequate breath samples excluded
Patient characteristics and set-
ting
Sample size: 60
Female: not stated
Age: not stated
Presentation:
1. Children with gastrointestinal symptoms
Setting: secondary care, Pakistan
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (10 minutes, 20 minutes, and 30 minutes)
Index test 2: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 6 (10%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
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Hafeez 2007 (Continued)
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
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Hafeez 2007 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Han 2012
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 99
Female: not stated
Age: not stated
Presentation:
1. Patients who had undergone urea breath tests and endoscopy
Setting: secondary care, South Korea
Index tests Index test: urea breath test - unknown isotope
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Han 2012 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test - unknown isotope
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Inelmen 2004
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 122
Female: 81 (66.4%)
Age: 80 years
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
Setting: secondary care, Italy
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: BreathQuality-UBT 13C-Urea Kit, Zeta Farmaceutici SpA
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 5.0% (30 minutes)
Index test 2: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA (Meridian Diagnostics)
Performed by: not stated
Criteria for positive diagnosis: definite yellow colour
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
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Inelmen 2004 (Continued)
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Inelmen 2004 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
Iqbal 2013
Study characteristics
Patient sampling Type of study: retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 50
Female: 19 (38%)
Age: 41 years
Presentation:
1. Patients who underwent upper gastrointestinal endoscopy
Setting: secondary care, Pakistan
Index tests Index test: serology
Further details:
Technical specifications: HpG screen ELISA kit
Performed by: not stated
Criteria for positive diagnosis: > 7 units/ml
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Iqbal 2013 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
202Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Islam 2005
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: neither - patients without stool samples excluded
Patient characteristics and set-
ting
Sample size: 112
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
Setting: secondary care, New Zealand
Index tests Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA (Meridian Diagnostics)
Performed by: pathologists
Criteria for positive diagnosis: Absorbance 450/630 nm > 0.120
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Immunoperoxidase stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 15 (11.8%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
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Islam 2005 (Continued)
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Ivanova 2010
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
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Ivanova 2010 (Continued)
Patient characteristics and set-
ting
Sample size: 33
Female: 16 (48.5%)
Age: 42 years
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
Setting: secondary care, Bulgaria
Index tests Index test: serology
Further details:
Technical specifications: Rapid HP, US Meds
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
Unclear
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Ivanova 2010 (Continued)
dard?
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Jekarl 2013
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with a recent antibiotic treatment were excluded
Patient characteristics and set-
ting
Sample size: 209
Female: 85 (40.7%)
Age: not stated
Presentation:
1. Patients undergoing routine health check-up and upper gastrointestinal endoscopy
Exclusion:
1. Recent ulcer or H pylori treatment
2. Previous gastric surgery
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Jekarl 2013 (Continued)
3. Previous gastric cancer
Setting: secondary care, Korea
Index tests Index test: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: Absence of yellow
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 57 (21.4%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
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Jekarl 2013 (Continued)
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Jensen 1998
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear
Patient characteristics and set-
ting
Sample size: 35
Female: not stated
Age: not stated
Presentation:
1. Patients referred for endoscopy
Exclusion:
Recent H pylori treatment
Setting: secondary care, USA
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: not stated
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Jensen 1998 (Continued)
Performed by: not stated
Criteria for positive diagnosis: disintegrations per minute > 200 (10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 7 (16.7%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
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Jensen 1998 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Jordaan 2008
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with previous gastrointestinal surgery excluded
Patient characteristics and set-
ting
Sample size: 103
Female: not stated
Age: not stated
Presentation:
1. Patients with dyspepsia
Exclusion criteria:
1. Recent H pylori therapy
2. Major gastrointestinal surgery
Setting: secondary care, South Africa
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.5% (time not stated)
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Jordaan 2008 (Continued)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 8 (7.2%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
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Jordaan 2008 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Kalach 1998a
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 35 (35%)
Age: 11 years
Presentation:
1. Children undergoing upper gastrointestinal endoscopy for recurrent epigastric pain or upper GI
tract disorders
Exclusion:
1. Recent H pylori treatment
Setting: secondary care, France
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > 6 IU /ml
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
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Kalach 1998a (Continued)
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
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Kalach 1998a (Continued)
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Kamel 2011
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 55
Female: not stated
Age: 67 years
Presentation:
1. Older adults with dyspepsia and no gastrointestinal bleeding
Setting: secondary care, Egypt
Index tests Index test: stool antigen test
Further details:
Technical specifications: CerTest H pylori Card
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
214Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kamel 2011 (Continued)
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
215Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kamel 2011 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Kim 2016
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 107
Female: 56 (52.3%)
Age: 41 years
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
Exclusion:
1. Recent H pylori treatment
Setting: secondary care, South Korea
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: UbiT-IR300 apparatus
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 2.5% (20 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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Kim 2016 (Continued)
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
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Kim 2016 (Continued)
Unclear
Korstanje 2006
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 20
Female: 9 (45%)
Age: 68 years
Presentation:
1. Patients with atrophic gastritis
Setting: primary care, Netherlands
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: INFAI, Bochum, Germany
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)
Index test 2: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: Absorbance (wavelength not stated) > 0.320
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Korstanje 2006 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear High
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
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Korstanje 2006 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Kuloglu 2008
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: neither - patients without a either a stool sample or a breath sample
excluded
Patient characteristics and set-
ting
Sample size: 109
Female: 58 (53.2%)
Age: 12 years
Presentation:
1. Children with symptoms suggestive of H pylori infection
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Turkey
Index tests Index test 1: urea breath test-14C
Further details:
Technical specifications: Heliprobe BreathCard
Performed by: not stated
Criteria for positive diagnosis: Counts per minute > 50 (10 minutes)
Index test 2: stool antigen test
Further details:
Technical specifications: Rapid HpSA test (L NEAR Chemical)
Performed by: not stated
Criteria for positive diagnosis: pinkish red band (within 10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
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Kuloglu 2008 (Continued)
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 16 (12.8%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
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Kuloglu 2008 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Ladas 2002a
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 130
Female: 48 (36.9%)
Age: 50 years
Presentation:
1. Patients with dyspepsia
Exclusion:
1. Recent H pylori therapy
2. Malignancy
3. Pregnancy
4. Gastric surgery
Setting: secondary care, Greece
Index tests Index test 1a: serology
Further details:
Technical specifications: Pyloriset EIA-G
Performed by: not stated
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Ladas 2002a (Continued)
Criteria for positive diagnosis: ≥ 300
Index test 1b: serology
Further details:
Technical specifications: Milenia H Pylori IgG
Performed by: not stated
Criteria for positive diagnosis: ≥ 44
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa and Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
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Ladas 2002a (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
Lahner 2004
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 27
Female: 19 (70.4%)
Age: 52 years
Presentation:
1. Patients with atrophic gastritis
Exclusion criteria:
1. Gastric surgery
2. Gastric malignancy
3. Recent H pylori treatment
4. Diarrhoea
5. Constipation
Setting: not stated
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Lahner 2004 (Continued)
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.5% (15 minutes and 30 minutes)
Index test 2: stool antigen test
Further details:
Technical specifications: HpSA, Meridian
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450 nm ≥ 0.160
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Lahner 2004 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
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Lee 1998
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 71
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy for duodenitis, gastritis, duodenal ulcer, gastric ulcer
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Singapore
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 6% (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
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Lee 1998 (Continued)
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Logan 1991a
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
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Logan 1991a (Continued)
Patient characteristics and set-
ting
Sample size: 50
Female: 24 (48%)
Age: 51 years
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
Exclusion criteria:
1. Recent H pylori infection
2. Previous gastric surgery
Setting: secondary care, UK
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > Mean + 3 standard deviations above normal level (60 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
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Logan 1991a (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
No
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Lombardo 2003
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - histology performed in a subset of patients
Patient characteristics and set-
ting
Sample size: 28
Female: not stated
Age: not stated
Presentation:
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Lombardo 2003 (Continued)
1. Patients who had undergone gastrectomy
Setting: secondary care, Italy
Index tests Index test: urea breath test - unknown isotope
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4 perml (at 5-minute intervals up to 30minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 72 (72%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High High
DOMAIN 2: Index Test Urea breath test - unknown isotope
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Lombardo 2003 (Continued)
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Lottspeich 2007
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with recent antibiotic treatment were excluded
Patient characteristics and set-
ting
Sample size: 56 for urea breath test, 100 for stool antigen test
Female: not stated
Age: 10 years
Presentation:
1. Children with abdominal symptoms undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Germany
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: not stated
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Lottspeich 2007 (Continued)
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 5.0% (30 minutes)
Index test 2: stool antigen test
Further details:
Technical specifications: IDEIA HpStAR assay (DakoCytomation)
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450/620 nm to 650 nm ≥ 0.150
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain or Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 44 (44%) for urea breath test; 0 (0%) for
stool antigen test
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Lottspeich 2007 (Continued)
Unclear Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Luthra 1998
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
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Luthra 1998 (Continued)
Patient characteristics and set-
ting
Sample size: 240
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
Excluded:
1. People with upper GI bleeding
2. People with coagulation abnormalities
Setting: not stated
Index tests Index test: serology
Further details:
Technical specifications: Pyloristat (BioWhittaker)
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain, immunostain, or Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
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Luthra 1998 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Mana 2001a
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 182
Female: not stated
Age: not stated
Presentation:
236Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Mana 2001a (Continued)
1. Patients undergoing upper gastrointestinal endoscopy
2. People not taking H pylori medication
Setting: secondary care, Belgium
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Multiple criteria for positive diagnosis:
• Delta over baseline > 3.0% (10 minutes)
• Delta over baseline > 3.0% (20 minutes)
• Delta over baseline > 3.0% (30 minutes)
• Delta over baseline > 3.5% (10 minutes)
• Delta over baseline > 3.5% (20 minutes)
• Delta over baseline > 3.5% (30 minutes)
• Delta over baseline > 4.0% (10 minutes)
• Delta over baseline > 4.0% (20 minutes)
• Delta over baseline > 4.0% (30 minutes)
• Delta over baseline > 4.5% (10 minutes)
• Delta over baseline > 4.5% (20 minutes)
• Delta over baseline > 4.5% (30 minutes)
• Delta over baseline > 5.0% (10 minutes)
• Delta over baseline > 5.0% (20 minutes)
• Delta over baseline > 5.0% (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with immunohistochemistry and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
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Mana 2001a (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
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Mansour-Ghanaei 2011
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 125
Female: 65 (52%)
Age: 36 years
Presentation:
1. Patients with dyspepsia
Exclusion:
1. Recent or past H pylori eradication
2. Pregnancy
3. Severe cardiopulmonary disorders or other life-threatening illnesses
Setting: secondary care, Iran
Index tests Index test 1: urea breath test-14C
Further details:
Technical specifications: Heliprobe BreathCard
Performed by: not stated
Criteria for positive diagnosis: Counts per minute > 50 (15 minutes)
Index test 2: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > 11 IU
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
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Mansour-Ghanaei 2011 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
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Mansour-Ghanaei 2011 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Mion 1994
Study characteristics
Patient sampling Type of study: retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 95
Female: not stated
Age: not stated
Presentation:
1. Patients with upper abdominal symptoms
Exclusion:
1. Patients with previous gastric surgery
Setting: secondary care, France
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > + 3 delta 0/00 (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
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Mion 1994 (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
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Mion 1994 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Misawa 1998
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 114
Female: 46 (40.4%)
Age: not stated
Presentation:
1. Patients with gastritis, gastric, or duodenal ulcers
Setting: secondary care, Japan
Index tests Index test 1a: serology (IgA)
Further details:
Technical specifications: GAP-IgA (BioMerica)
Performed by: not stated
Criteria for positive diagnosis: not stated
Index test 1b: serology (IgG)
Further details:
Technical specifications: GAP-IgG (BioMerica)
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with immunostaining (Carnoy’s solution)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
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Misawa 1998 (Continued)
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
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Misawa 1998 (Continued)
Were all patients included in the
analysis?
Unclear
Unclear
Mohammadian 2007
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 179
Female: 108 (60.3%)
Age: 54 years
Presentation:
1. Patients undergoing endoscopy for gastrointestinal problems
Setting: secondary care, Iran
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Mohammadian 2007 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Monteiro 2001a
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 104
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori therapy
2. Bleeding disorders or other conditions with contraindication for endoscopy or biopsy
Setting: secondary care, France
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: ABCA, Europa Scientific
Performed by: not stated
Criteria for positive diagnosis: not stated
Index test 2a: serology
Further details:
Technical specifications: Pyloriset EIA Kit (Orion Diagnostica)
Performed by: not stated
Criteria for positive diagnosis: > = 300
Index test 2b: serology
Further details:
Technical specifications: Helicoblot Immunoblot kit
Performed by: not stated
Criteria for positive diagnosis: not stated
Index test 3: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA, Meridian
Performed by: not stated
Criteria for positive diagnosis: Absorbance (wavelength not reported) > = 0.160
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
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Monteiro 2001a (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Monteiro 2001a (Continued)
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Morales 1995
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 104
Female: 52 (50%)
Age: 50 years
Presentation:
1. Patients with upper abdominal symptoms
Setting: Outpatients, Mexico
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Morales 1995 (Continued)
Index tests Index test 1: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Multiple criteria for positive diagnosis:
First criterion: ≥ 1.6% excretion (time not stated)
Second criterion: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
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Morales 1995 (Continued)
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Noguera 1998
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear
Patient characteristics and set-
ting
Sample size: 38
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing urea breath tests and endoscopic biopsy
Setting: secondary care, Argentina
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Multiple criteria for positive diagnosis:
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Noguera 1998 (Continued)
• > 1% excretion (10 minutes)
• > 1% excretion (20 minutes)
• > 1% excretion (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 87 (69.6%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
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Noguera 1998 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Novis 1991
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 76
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy for gastrointestinal symptoms
Setting: secondary care, Israel
Index tests Index test 1: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Multiple criteria for positive diagnosis:
• > 4.7% excretion (5 minutes)
• > 4.7% excretion (10 minutes)
• > 4.7% excretion (15 minutes)
• > 4.7% excretion (20 minutes)
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Novis 1991 (Continued)
• > 4.7% excretion (25 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
Yes
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Novis 1991 (Continued)
condition?
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Ogata 2001
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 47
Female: 27 (57.4%)
Age: 12 years
Presentation:
1. Children with dyspepsia undergoing endoscopy
Exclusion:
1. Recent H pylori treatment
2. Immunosuppressive treatment or chemotherapy
3. Extradigestive disease
Setting: secondary care, Brazil
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: Isomed
Performed by: not stated
Criteria for positive diagnosis: > 3% excretion (time not stated)
Index test 2: serology
Further details:
Technical specifications: Cobas Core II (Roche)
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Ogata 2001 (Continued)
Performed by: not stated
Criteria for positive diagnosis: > 7 U/ml
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear High
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Serology
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Ogata 2001 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Ozturk 2003
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 73
Female: 56 (74.6%)
Age: 41 years
Presentation:
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Ozturk 2003 (Continued)
1. Patients with dyspepsia
Setting: secondary care, Turkey
Index tests Index test 1a: urea breath test-14C
Further details:
Technical specifications: Heliprobe BreathCard
Performed by: not stated
Criteria for positive diagnosis: Counts per minute > 50 (10 minutes)
Index test 1b: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: disintegrations per minute > 100 (10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
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Ozturk 2003 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Peitz 2001
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 145
Female: 87 (60%)
Age: 59 years
Presentation:
1. Patients with dyspepsia
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Peitz 2001 (Continued)
Exclusion criteria:
1. Recent H pylori treatment
2. Recent NSAID treatment
3. Previous gastric surgery
4. Clotting disorders
Setting: secondary care, Germany
Index tests Index test: serology
Further details:
Technical specifications: Helisa Rapid Whole Blood Test (Cortecs Diagnostics Ltd)
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
Unclear
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Peitz 2001 (Continued)
dard?
If a threshold was used, was it
pre-specified?
Yes
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
Peura 1996
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 200
Female: 118 (59%)
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
2. Gastric surgery
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Peura 1996 (Continued)
Setting: secondary care, USA
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: disintegrations per minute > 200 (10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Peura 1996 (Continued)
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Puspok 1999
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 72
Female: 42 (58.3%)
Age: 55 years
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Austria
Index tests Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA (Meridian Diagnostics)
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Puspok 1999 (Continued)
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450/620 nm ≥ 0.100
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
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Puspok 1999 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
Qadeer 2009
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 50 (50%)
Age: 39 years
Presentation:
1. Patients with dyspepsia
Exlusion criteria:
1. Recent H pylori therapy
2. Not on anti-coagulant therapy
3. Oral anticoagulants or NSAID treatment
Setting: secondary care, Pakistan
Index tests Index test: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: pink-red band
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Qadeer 2009 (Continued)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Qadeer 2009 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Rafeey 2007
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 96
Female: 31 (32.3%)
Age: 8 years
Presentation:
1. Children with dyspepsia or abdominal pain
Exclusion criteria:
1. Recent H pylori treatment
2. Diarrhoea
Setting: secondary care, Iran
Index tests Index test: stool antigen test
Further details:
Technical specifications: Equipar HPSA test
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
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Rafeey 2007 (Continued)
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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Rafeey 2007 (Continued)
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Rasool 2007
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 94
Female: 34 (36.2%)
Age: 41 years
Presentation:
1. Patients with dyspepsia
Exclusion criteria:
1. Recent H pylori treatment
2. Pregnancy
3. Gastric surgery
Setting: secondary care, Pakistan
Index tests Index test: urea breath test
Further details:
Technical specifications: Heliprobe BreathCard
Performed by: not stated
Criteria for positive diagnosis: Counts per minute > 50 (10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
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Rasool 2007 (Continued)
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
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Rasool 2007 (Continued)
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Rathbone 1986
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 73
Female: not stated
Age: not stated
Presentation:
1. Patients with dyspepsia
Setting: secondary care, UK
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > Mean + 2 standard deviations above normal level
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
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Rathbone 1986 (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Rathbone 1986 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Safe 1993
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 59 (59%)
Age: 72 years
Presentation:
1. Elderly dyspeptic patients
Setting: secondary care, UK
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > 10 units/ml
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Safe 1993 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Salles-Montaudon 2002
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 107
Female: 71 (66.4%)
Age: 85 years
Presentation:
1. Adults > 75 years
Exclusion criteria:
1. Contraindication to biopsy
Setting: secondary care, Switzerland
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: ABCA, Europa Scientific
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 3.5% (30 minutes)
Index test 2: serology
Further details:
Technical specifications: Pyloriset EIA Kit (Orion Diagnostica)
Performed by: not stated
Criteria for positive diagnosis: > 300 Units
Index test 3: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA, Meridian
Performed by: not stated
Criteria for positive diagnosis: Absorbance (wavelength not reported) > 0.160
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Salles-Montaudon 2002 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
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Salles-Montaudon 2002 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Schilling 2001
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 68
Female: 20 (29.4%)
Age: 62 years
Presentation:
1. Patients with partial gastric resection
Exclusion criteria:
Recent H pylori treatment
Setting: secondary care, Germany
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)
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Schilling 2001 (Continued)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear High
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Schilling 2001 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Scuderi 2000
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 250
Female: 127 (50.8%)
Age: 58 years
Presentation:
1. Patients with dyspeptic symptoms
Setting: secondary care, Italy
Index tests Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA (Meridian Diagnostics)
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
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Scuderi 2000 (Continued)
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
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Scuderi 2000 (Continued)
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Segamwenge 2014
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with recent antibiotic treatment were excluded
Patient characteristics and set-
ting
Sample size: 160
Female: not stated
Age: not stated
Presentation:
1. Patients with dyspepsia
Exclusion criteria
1. Could not tolerate endoscopy
2. Recent H pylori treatment
3. Pain attributable to pancreas or liver
4. NSAID-related dyspepsia
Setting: secondary care, Italy
Index tests Index test: stool antigen test
Further details:
Technical specifications: Rapid strip HPSA (Meridian Bioscience)
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
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Segamwenge 2014 (Continued)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
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Segamwenge 2014 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Selcukcan 2011
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 47 (47%)
Age: not stated
Presentation:
1. Infants undergoing endoscopy
Exclusion criteria:
1. No recent H pylori treatment
Setting: secondary care, Turkey
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
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Selcukcan 2011 (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Selcukcan 2011 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Sharbatdaran 2013
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 61
Female: 36 (59%)
Age: 31 years
Presentation:
1. Patients with dyspepsia
Exclusion criteria:
1. Recent H pylori infection
2. Gastric cancer
3. Bleeding during endoscopy
Setting: secondary care, Iran
Index tests Index test: stool antigen test
Further details:
Technical specifications: GA Generic Assay
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450 nm > + 0.1 of negative control
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
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Sharbatdaran 2013 (Continued)
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
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Sharbatdaran 2013 (Continued)
Were all patients included in the
analysis?
Yes
Unclear
Sheu 1998a
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 135
Female: not stated
Age: not stated
Presentation:
1. Patients with dyspepsia
Setting: secondary care, Mexico
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not clearly stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Sheu 1998a (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Sheu 1998b
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 66
Female: not stated
Age: not stated
Presentation:
1. Patients with gastrectomy
Setting: secondary care, Mexico
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not clearly stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear High
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Sheu 1998b (Continued)
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Shin 2009
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 651
Female: 254 (39%)
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Shin 2009 (Continued)
Age: 58 years
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
2. Chronic medication
3. Gastric surgery
Setting: secondary care, South Korea
Index tests Index test: serology
Further details:
Technical specifications: Genedia H pylori
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450 nm > 0.406
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
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Shin 2009 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Soomro 2012
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 44 (44%)
Age: not stated
Presentation:
1. Patients undergoing endoscopic biopsy for dyspepsia or gastritis
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Soomro 2012 (Continued)
Setting: secondary care, Pakistan
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Index test: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
Unclear
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Soomro 2012 (Continued)
dard?
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Surveyor 1989
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 63
Female: 30 (47.8%)
Age: 59 years
Presentation:
1. Patients with symptoms related to upper gastrointestinal tract undergoing endoscopy
Setting: secondary care, Australia
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain, Warthin-Starry stain, and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
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Surveyor 1989 (Continued)
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
Thobani 1995
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 26
Female: not stated
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Thobani 1995 (Continued)
Age: not stated
Presentation:
1. Patients with upper gastrointestinal symptoms
Setting: secondary care, Pakistan
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > 2
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Thobani 1995 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Tiwari 2014
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 30
Female: 25 (83.3%)
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, India
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Tiwari 2014 (Continued)
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: disintegrations per minute > 200 (10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
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Tiwari 2014 (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Trevisani 2005
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 105
Female: 50 (47.6%)
Age: 58 years
Presentation:
1. Patients referred to endoscopy centre
Exclusion criteria:
1. Recent H pylori treatment
2. Pregnancy or lactation
3. Steroids or NSAID treatment
4. Prior gastric surgery
5. Bleeding peptic ulcer
6. Severe concomitant diseases
Setting: secondary care, Italy
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Trevisani 2005 (Continued)
Index tests Index test 1a: stool antigen test
Further details:
Technical specifications: Amplified IDEA Hp StAR
Performed by: doctor
Criteria for positive diagnosis: Absorbance 450 nm ≥ 0.190
Index test 1b: stool antigen test
Further details:
Technical specifications: Immunocard Stat
Performed by: doctor
Criteria for positive diagnosis: pink red band (5 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
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Trevisani 2005 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Vandenplas 1992
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 95
Female: 50 (52.6%)
Age: 9 years
Presentation:
1. Children with chronic abdominal pain
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Belgium
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Vandenplas 1992 (Continued)
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not clearly stated
Index test 2: serology
Further details:
Technical specifications: Malakit Helicobacter pylori (Biolab)
Performed by: not stated
Criteria for positive diagnosis: > Mean + 3 standard deviations above normal level
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Vandenplas 1992 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
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Villalobos 1992
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 105
Female: 69 (65.7%)
Age: not stated
Presentation:
1. Patients with dyspepsia
Excluded:
1. Recent H pylori treatment
2. Patients taking steroids
3. Patients with coagulopathy
4. Patients allergic to penicillin
5. Pregnancy or lactation
Setting: secondary care, Mexico
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: disintegrations per minute > 1.6% (60 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
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Villalobos 1992 (Continued)
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Wang 2008
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with recent antibiotic treatment were excluded
Patient characteristics and set-
ting
Sample size: 123
Female: 69 (56.1%)
Age: 48 years
Presentation:
1. Asymptomatic individuals
Exclusion criteria:
1. Recent H pylori therapy
2. Gastric surgery
Setting: secondary care, Italy
Index tests Index test: serology
Further details:
Technical specifications: Assure H pylori Rapid Test (CIM-test, Genelabs Diagnostics Ltd)
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain, Warthin-Starry stain, and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 214 (63.5%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
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Wang 2008 (Continued)
High Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
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Wardi 2012
Study characteristics
Patient sampling Type of study: retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 76
Female: 15 (19.7%)
Age: 70 years
Presentation:
1. Patients with partial gastrectomy
Setting: secondary care, Israel
Index tests Index test: urea breath test - C13
Further details:
Technical specifications: BreathID
Performed by: not stated
Criteria for positive diagnosis: not clearly stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear High
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Wardi 2012 (Continued)
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Weiss 1994
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 95
Female: not stated
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Weiss 1994 (Continued)
Age: not stated
Presentation:
1. Patients with abdominal pain
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, USA
Index tests Index test 1a: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Index test 1b: serology
Further details:
Technical specifications: Cobas Core anti-H pylori (Roche)
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
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Weiss 1994 (Continued)
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Yan 2003
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with recent antibiotic treatment were excluded
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Yan 2003 (Continued)
Patient characteristics and set-
ting
Sample size: 31
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, China
Index tests Index test: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450/630 nm ≥ 0.120
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 32 (50.8%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Stool Antigen Test
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Yan 2003 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Yoshimura 2001
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 72
Female: 34 (47.2%)
Age: 13 years
Presentation:
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Yoshimura 2001 (Continued)
1. Children undergoing endoscopy for symptoms such as anaemia and abdominal pain
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Japan
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 3.0% (20 minutes and 30 minutes)
Index test 2: serology
Further details:
Technical specifications: HM-CAP Anti-H pylori-EIA; Kyowa Medics
Performed by: not stated
Criteria for positive diagnosis: ≥ 1.8
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
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Yoshimura 2001 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Yu 1999
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with recent antibiotic treatment were excluded
Patient characteristics and set-
ting
Sample size: 88
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Singapore
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 16 (16.5%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
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Yu 1999 (Continued)
High Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Yu 2001
Study characteristics
Patient sampling Type of study: retrospective study
Consecutive or random sample: consecutive patients
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Yu 2001 (Continued)
Patient characteristics and set-
ting
Sample size: 32
Female: 14 (43.8%)
Age: 51 years
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
2. Gastric surgery
Setting: secondary care, Taiwan, China
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 2.8% (15 minutes)
Index test 2: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA, Meridian
Performed by: not stated
Multiple criteria for positive diagnosis:
• Absorbance 450 nm > 0.140
• Visual assessment by gastroenterologists
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
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Yu 2001 (Continued)
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Yu 2001 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
CO2 - carbon dioxide;
H & E stain - haematoxylin and eosin stain;
HpSA - H pylori stool antigen;
IgA - immunoglobulin A;
IgG - immunoglobulin G;
NMR - nuclear magnetic resonance;
NSAID - non-steroidal anti-inflammatory
WBC - white blood cell
All other acronyms and abbreviations are the full title of either products or companies producing products included in the study.
Characteristics of studies awaiting classification [ordered by study ID]
Buhigas-Garcia 2008
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests urea breath test-13C
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
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Fazeli 2004
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests salivary test, potential index tests of interest
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Fuke 2009
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests serology
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Glupczynski 1991
Study characteristics
Patient sampling
Patient characteristics and set-
ting
322Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Glupczynski 1991 (Continued)
Index tests urea breath test-13C
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Karczewska 1997
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests serology
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Kushch 2014
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests unclear
Target condition and reference
standard(s)
Flow and timing
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Kushch 2014 (Continued)
Comparative
Notes
Lappas 1997
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests salivary test, potential index tests of interest
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Lee 1999a
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests urea breath test-13C
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
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Martin-de-Argila 1997
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests serology
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Mason 1997
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests urea breath test
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Thong-Ngam 2011
Study characteristics
Patient sampling
Patient characteristics and set-
ting
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Thong-Ngam 2011 (Continued)
Index tests serology
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Tokunaga 2005a
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests urea breath test
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Xu 1995
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests urea breath test-13C
Target condition and reference
standard(s)
Flow and timing
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Xu 1995 (Continued)
Comparative
Notes
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D A T A
Presented below are all the data for all of the tests entered into the review.
Tests. Data tables by test
Test
No. of
studies
No. of
participants
1 Urea breath test-13C 34 3139
2 Urea breath test-14C 21 1810
3 Urea breath test - Unknown
isotope
2 127
4 Serology 34 4242
5 Stool antigen test 29 2988
6 Urea breath test-13C (delta over
baseline > 3% (20 minutes))
2 254
7 Urea breath test-13C (delta over
baseline > 3% (30 minutes))
3 333
8 Urea breath test-13C (delta over
baseline > 3.5% (30 minutes))
3 368
9 Urea breath test-13C (delta over
baseline > 4% (10 minutes))
2 236
10 Urea breath test-13C (delta over
baseline > 4% (20 minutes))
2 236
11 Urea breath test-13C (delta over
baseline > 4% (30 minutes))
10 958
12 Urea breath test-13C (delta over
baseline > 4.5% (30 minutes))
3 288
13 Urea breath test-13C (delta over
baseline > 5% (30 minutes))
4 601
14 Urea breath test-14C (counts
per minute > 50)
6 471
15 Urea breath test-14C
(disintegrations per minute >
200)
4 296
16 Serology > 7 units/ml 2 97
17 Serology ≥300 units 2 234
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A D D I T I O N A L T A B L E S
Table 1. Summary of results at thresholds commonly reported for urea breath test-13C, urea breath test-14C and serology
Threshold Studies Number of participants
(cases)
Sensitivity (95% CI) Specificity (95% CI)
Urea breath test-13C
Delta over baseline > 3%
(20 minutes)
2 254 (128) 0.98 (0.90 to 1.00) 0.92 (0.82 to 0.97)
Delta over baseline > 3%
(30 minutes)
3 333 (140) 0.99 (0.92 to 1.00) 0.95 (0.90 to 0.98)
Delta over baseline > 3.
5% (30 minutes)
3 368 (120) 0.75 to 1.00 0.77 to 1.00
Delta over baseline > 4%
(10 minutes)
2 236 (118) 0.91 to 1.00 0.60 to 0.95
Delta over baseline > 4%
(20 minutes)
2 236 (118) 0.91 to 1.00 0.60 to 0.96
Delta over baseline > 4%
(30 minutes)
10 958 (423) 0.95 (0.79 to 0.99) 0.95 (0.87 to 0.98)
Delta over baseline > 4.
5% (30 minutes)
3 288 (106) 0.50 to 0.96 0.82 to 0.96
Delta over baseline > 5%
(30 minutes)
4 601 (315) 0.95 (0.49 to 1.00) 0.94 (0.84 to 0.98)
Urea breath test-14C
Counts per minute > 50
(10 minutes)
6 471 (231) 0.89 (0.55 to 0.98) 0.91 (0.79 to 0.96)
Disintegrations per
minute > 200 (10 min-
utes)
4 296 (132) 0.95 (0.33 to 1.00) 0.95 (0.80 to 0.99)
Serology
> 7 units/ml 2 97 (48) 0.98 (0.74 to 1.00) 0.71 (0.51 to 0.86)
≥ 300 unit 2 234 (143) 0.91 (0.82 to 0.96) 0.86 (0.72 to 0.93)
Tests evaluated at the same threshold by more than one study are presented in the table. When there were two or three studies at the
same threshold, and little or no heterogeneity was observed in ROC space, estimates of summary sensitivity and summary specificity
were obtained by using univariate fixed-effect logistic regression models to pool sensitivities and specificities separately. When there
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were two or three studies and we observed heterogeneity, we did not perform meta-analysis but report the range of the sensitivities
and specificities.
Table 2. Indirect comparison of the accuracy of non-invasive tests for H pylori infection
Index tests Studies;
participants (H py-
loripresent)
DOR (95% CI) Ratio of diagnostic odds ratios (95% CI), P value
Urea breath test-
13C
Urea breath test-
14C
Serology
Urea breath test-
13C
34; 3139 (1526) 153 (73.7 to 316) - - -
Urea breath test-
14C
21; 1810 (1018) 105 (74.0 to 150) 1.45 (0.65 to 3.26),
P = 0.36
- -
Serology 34; 4242 (2477) 47.4 (25.5 to 88.1) 3.22 (1.24 to 8.37),
P = 0.017
2.22 (1.09 to 4.51),
P = 0.028
-
Stool antigen test 29; 2988 (1311) 45.1 (24.2 to 84.1) 3.39 (1.30 to 8.83),
P = 0.013
2.33 (1.14 to 4.76),
P = 0.020
1.05 (0.44 to 2.53),
P = 0.91
The indirect comparison included all studies that evaluated at least one of the four tests, i.e. all available data. The ratio of diagnostic
odds ratios is the diagnostic odds ratio (DOR) of the test in the column divided by the DOR of the test in the row. If the ratio is
greater than one, then the test in the column is more accurate than the test in the row; if the ratio is less than one, the test in the
row is more accurate than the test in the column.
Table 3. Accuracy of non-invasive tests for H pylori infection at different levels of prevalence
Prevalence (%) Specificity False positives1 Test Sensitivity (95% CI) Missed cases (95% CI)
42.0 0.79 122 Urea breath test-13C 0.98 (0.95 to 0.99) 10 (5 to 20)
Urea breath test-14C 0.97 (0.95 to 0.98) 15 (10 to 20)
Serology 0.93 (0.87 to 0.96) 31 (17 to 54)
Stool antigen test 0.92 (0.87 to 0.96) 32 (18 to 57)
53.7 0.79 97 Urea breath test-13C 0.98 (0.95 to 0.99) 13 (6 to 26)
Urea breath test-14C 0.97 (0.95 to 0.98) 19 (13 to 26)
Serology 0.93 (0.87 to 0.96) 39 (22 to 69)
Stool antigen test 0.92 (0.87 to 0.96) 41 (23 to 72)
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Table 3. Accuracy of non-invasive tests for H pylori infection at different levels of prevalence (Continued)
66.5 0.79 70 Urea breath test-13C 0.98 (0.95 to 0.99) 16 (8 to 32)
Urea breath test-14C 0.97 (0.95 to 0.98) 23 (16 to 32)
Serology 0.93 (0.87 to 0.96) 49 (27 to 85)
Stool antigen test 0.92 (0.87 to 0.96) 51 (28 to 89)
42.0 0.90 58 Urea breath test-13C 0.94 (0.89 to 0.97) 23 (12 to 46)
Urea breath test-14C 0.92 (0.89 to 0.94) 33 (24 to 46)
Serology 0.84 (0.74 to 0.91) 67 (39 to 110)
Stool antigen test 0.83 (0.73 to 0.90) 70 (41 to 114)
53.7 0.90 46 Urea breath test-13C 0.94 (0.89 to 0.97) 30 (15 to 58)
Urea breath test-14C 0.92 (0.89 to 0.94) 42 (30 to 58)
Serology 0.84 (0.74 to 0.91) 86 (50 to 140)
Stool antigen test 0.83 (0.73 to 0.90) 89 (52 to 146)
66.5 0.90 34 Urea breath test-13C 0.94 (0.89 to 0.97) 37 (18 to 72)
Urea breath test-14C 0.92 (0.89 to 0.94) 53 (38 to 72)
Serology 0.84 (0.74 to 0.91) 106 (62 to 173)
Stool antigen test 0.83 (0.73 to 0.90) 111 (64 to 180)
42.0 0.96 23 Urea breath test-13C 0.86 (0.75 to 0.93) 57 (30 to 103)
Urea breath test-14C 0.81 (0.76 to 0.86) 78 (58 to 103)
Serology 0.66 (0.52 to 0.79) 141 (90 to 204)
Stool antigen test 0.65 (0.50 to 0.78) 146 (93 to 209)
53.7 0.96 19 Urea breath test-13C 0.86 (0.75 to 0.93) 73 (38 to 132)
Urea breath test-14C 0.81 (0.76 to 0.86) 100 (74 to 132)
Serology 0.66 (0.52 to 0.79) 181 (115 to 260)
Stool antigen test 0.65 (0.50 to 0.78) 187 (119 to 267)
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Table 3. Accuracy of non-invasive tests for H pylori infection at different levels of prevalence (Continued)
66.5 0.96 13 Urea breath test-13C 0.86 (0.75 to 0.93) 90 (47 to 163)
Urea breath test-14C 0.81 (0.76 to 0.86) 124 (92 to 163)
Serology 0.66 (0.52 to 0.79) 224 (142 to 322)
Stool antigen test 0.65 (0.50 to 0.78) 231 (148 to 331)
1Average number of participants who are diagnosed with H pylori infection but do not have the infection per 1000 tested.
The sensitivities were estimated from the SROC curves at fixed values (lower quartile, median and upper quartile) of specificity from
the included studies across all tests. Based on these sensitivities and specificities, and quartiles of prevalence from the included studies
(across all tests), the numbers of missedH pylori cases and false positives (i.e. overdiagnosed people) were calculated using a hypothetical
cohort of 1000 people suspected of having H pylori infection.
Table 4. Direct comparison of the accuracy of non-invasive tests for H pylori infection
Test Urea breath test-13C Urea breath test-14C Serology
Urea breath test-13C - - -
Urea breath test-14C N = 0 - -
Serology N = 7
DOR(95%CI) of urea breath test-
13C = 74.8 (95% CI 17.8 to 314)
DOR (95% CI) of serology = 111
(95% CI 41.2 to 297)
RDORs (95% CI) of urea breath
test-13C versus serology, P value =
0.68 (95% CI 0.12 to 3.70), P =
0.56
N = 1 -
Stool antigen test N = 7
DOR(95%CI) of urea breath test-
13C = 46.6 (95% CI 3.30 to 658)
DOR (95% CI) of stool antigen
test = 53.0 (95% CI 5.34 to 527)
RDORs (95% CI) of urea breath
test-13C versus stool antigen test,
P value = 0.88 (95% CI 0.14 to 5.
56), P = 0.84
N = 2 N = 4
DOR = diagnostic odds ratio; N = number of studies; RDORs = ratio of diagnostic odds ratios.
Due to paucity of data and substantial heterogeneity observed in ROC space which precluded the use of simpler meta-analytic models,
meta-analyses were not possible for two test comparisons that had more than one study. For the single study of urea breath test-14C
versus serology (Mansour-Ghanaei 2011), both tests had similar sensitivity, but specificity was higher for urea breath test-14C than for
serology. The ratio of diagnostic odds ratios is the DOR of the test in the column divided by the DOR of the test in the row. If the
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ratio is greater than one, then the test in the column is more accurate than the test in the row; if the ratio is less than one, the test in
the row is more accurate than the test in the column.
C O N T R I B U T I O N S O F A U T H O R S
LB, SS, AS, AG, BL, and KG identified studies and extracted data for the review. LB entered the characteristics of included and excluded
studies. KG and YT analysed the data and wrote the review. MY provided critical comments for the review.
D E C L A R A T I O N S O F I N T E R E S T
This report is independent research funded by the National Institute for Health Research (NIHR Cochrane Programme Grants, 13/
89/03 - Evidence-based diagnosis and management of upper digestive, hepato-biliary, and pancreatic disorders). The views expressed
in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the
Department of Health.
LB: none known.
SS: none known.
AS: none known.
AG: none known.
BL: none known.
MY: is an Editor with the Cochrane Upper GI and Pancreatic Diseases (UGPD) Review Group. However, other UGPD Editors were
responsible for the editorial processing of this review.
KS: none known.
YT: none known.
S O U R C E S O F S U P P O R T
Internal sources
• University College London, UK.
External sources
• National Institute for Health Research, UK.
This project was supported by the National Institute for Health Research, via Cochrane Programme Grant to the CHBG and UGPD
groups. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic
Reviews Programme, NIHR, NHS or the Department of Health.
333Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
• We considered urea breath test-14C and urea breath test-13C as different index tests.
• Because of the paucity of data, we did not stratify the analysis by reference standard; however, we investigated reference standard
as a potential source of heterogeneity.
• Because studies reported different thresholds and following recommendation from peer reviewers, we used the HSROC model
for the primary analyses. For estimation of summary sensitivities and specificities at specific thresholds, we used univariate fixed- and
random-effects logistic regression models due to paucity of data.
• We performed direct comparisons whenever possible, rather than deciding this on the basis of the number of studies.
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